Any drug used in the treatment of acute or chronic vascular hypertension regardless of pharmacological mechanism.
| Member | Definition | Class |
|---|
| 1-0-octadecyl 2-0-acetyl sn-glycero-3-phosphorylcholine | A 2-acetyl-1-alkyl-sn-glycero-3-phosphocholine betaine which has octadecyl as the alkyl group. PAF is a potent phospholipid activator and mediator of many leukocyte functions, including platelet aggregation, inflammation, and anaphylaxis. | 2-O-acetyl-1-O-octadecyl-sn-glycero-3-phosphocholine |
| 1-hexadecyl-2-acetyl-glycero-3-phosphocholine | A 2-acetyl-1-alkyl-sn-glycero-3-phosphocholine betaine which has hexadecyl as the alkyl group. PAF is a potent phospholipid activator and mediator of many leukocyte functions, including platelet aggregation, inflammation, and anaphylaxis. | 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine |
| 2-hydroxy-9-cis-octadecenoic acid | A 2-hydroxy fatty acid that is oleic acid which carries a hydroxy group at position 2. It is an orally bioavailable synthetic hydroxylated fatty acid which modulates the lipid content of cancer cell membranes and induces cell cycle arrest and apoptosis in several cancer cell lines. | 2-hydroxyoleic acid |
| 4-hydroxychalcone | A member of the class of chalcones that is trans-chalcone substituted by a hydroxy group at position 4. | 4-hydroxychalcone |
| acebutolol | An ether that is the 2-acetyl-4-(butanoylamino)phenyl ether of the primary hydroxy group of 3-(propan-2-ylamino)propane-1,2-diol. | acebutolol |
| acebutolol hydrochloride | The hydrochloride salt of acebutolol, prepared using equimolar amounts of acebutolol and hydrogen chloride. | acebutolol hydrochloride |
| act-132577 | A member of the class of sulfamides in which one of the amino groups of sulfonamide is substituted by a 5-(4-bromophenyl)-6-{2-[(5-bromopyrimidin-2-yl)oxy]ethoxy}pyrimidin-4-yl group. An active metabolite of macitentan (obtained by oxidative depropylation), an orphan drug used for the treatment of pulmonary arterial hypertension. | ACT-132577 |
| alfuzosin | | alfuzosin |
| aliskiren | A monomethoxybenzene compound having a 3-methoxypropoxy group at the 2-position and a multi-substituted branched alkyl substituent at the 4-position. | aliskiren |
| alprenolol | A secondary alcohol that is propan-2-ol substituted by a 2-allylphenoxy group at position 1 and an isopropylamino group at position 3. It is a beta-adrenergic antagonist used as a antihypertensive, anti-arrhythmia and a sympatholytic agent. | alprenolol |
| amlodipine | A fully substituted dialkyl 1,4-dihydropyridine-3,5-dicarboxylate derivative, which is used for the treatment of hypertension, chronic stable angina and confirmed or suspected vasospastic angina. | amlodipine |
| amlodipine besylate | The benzenesulfonate salt of amlodipine. | amlodipine benzenesulfonate |
| angiotensin i | A nine amino acid peptide which is formed when angiotensin converting enzyme 2 (ACE2) hydrolyzes the carboxy terminal leucine from angiotensin I. It is a anti-cardiac hypertrophy agent. | angiotensin (1-9) dizwitterion; angiotensin (1-9) |
| angiotensin i | A peptide zwitterion that is the dizwitterionic form of angiotensin (1-9) having both carboxy groups deprotonated and the aspartyl amino group and arginine side-chain protonated. It is the major species at pH 7.3. | angiotensin (1-9) dizwitterion; angiotensin (1-9) |
| apelin-13 peptide | A 13 amino acid oligopeptide which is the ligand for the apelin receptor (also known as the APJ receptor). It exhibits hypotensive and neuroprotective effects, and may be a potential prognostic biomarker for acute ischemic stroke and multiple sclerosis. | apelin-13 |
| atenolol | An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent. | atenolol |
| aurapten | A member of the class of coumarins that is umbelliferone in which the phenolic hydrogen has been replaced by a geranyl group. Ii is isolated from several edible fruits and vegetables and exhibits a variety of therapeutic properties. | auraptene |
| avapro | A biphenylyltetrazole that is an angiotensin II receptor antagonist used mainly for the treatment of hypertension. | irbesartan |
| azilsartan | A benzimidazolecarboxylic acid that is benzimidazole-7-carboxylic acid substituted at position 2 by a methoxy group and at position 1 by a 2'-[(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methyl group. Used (as the prodrug, azilsartan medoxomil) for treatment of hypertension. | azilsartan |
| bay 58-2667 | A benzoic acid that is 4-(aminomethyl)benzoic acid in which the amino group is substituted by 4-carboxybutyl and 2-(2-{[4-(2-phenylethyl)benzyl]oxy}phenyl)ethyl groups. It is a soluble guanylate cyclase activator, used for the treatment of acute decompensated heart failure. | cinaciguat |
| bay 60-4552 | A member of the class of pyrazolopyridines that is 1H-pyrazolo[3,4-b]pyridine which is substituted by a 2-fluorobenzyl and 4,6-diamino-5-[(methoxycarbonyl)amino]pyrimidin-2-yl groups at positions 1 and 3, respectively. It is an active metabolite of riociguat and a soluble guanylate cyclase stimulator developed by Bayer for the treatment of erectile dysfunction and heart failure. | nelociguat |
| bay 63-2521 | A carbamate ester that is the methyl ester of {4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl}methylcarbamic acid. It is used for treatment of chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension | riociguat |
| bendroflumethiazide | A sulfonamide consisting of 7-sulfamoyl-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide in which the hydrogen at position 6 is substituted by a trifluoromethyl group and that at position 3 is substituted by a benzyl group. | bendroflumethiazide |
| benzothiazide | 7-Sulfamoyl-1,2,4-benzothiadiazine 1,1-dioxide in which the hydrogen at position 6 is substituted by chlorine and that at position 3 is substituted by a benzylsulfanylmethyl group. A diuretic, it is used to treat hypertension and edema. | benzthiazide |
| bepridil | A tertiary amine in which the substituents on nitrogen are benzyl, phenyl and 3-(2-methylpropoxy)-2-(pyrrolidin-1-yl)propyl. | bepridil |
| beraprost | An organic heterotricyclic compound that is (3aS,8bS)-2,3,3a,8b-tetrahydro-1H-benzo[b]cyclopenta[d]furan in which the hydrogens at positions 1R, 2R and 5 are replaced by (3S)-3-hydroxy-4-methyloct-1-en-6-yn-1-yl, hydroxy and 3-carboxypropyl groups, respectively. It is a prostaglandin receptor agonist which is approved to treat pulmonary arterial hypertension in Asia. | beraprost |
| beraprost sodium | The organic sodium salt of beraprost. It is used in the treatment of chronic arterial occlusive disease and primary pulmonary hypertension in Japan. | beraprost sodium |
| betaxolol | A propanolamine that is 3-aminopropane-1,2-diol in which the hydrogen of the primary hydoxy is substituted by a 4-[2-(cyclopropylmethoxy)ethyl]phenyl group and one of the hydrogens attached to the amino group is substituted by isopropyl. It is a selective beta1-receptor blocker and is used in the treatment of glaucoma as well as hypertension, arrhythmias, and coronary heart disease. It is also used to reduce non-fatal cardiac events in patients with heart failure. | betaxolol |
| betaxolol hydrochloride | The hydrochloride salt of betaxolol. | betaxolol hydrochloride |
| bethanidine | | bethanidine |
| bevantolol | A propanolamine that is 3-aminopropane-1,2-diol in which the hydrogen of the primary hydroxy group is substituted by 3-methylphenyl and one of the hydrogens attached to the nitrogen is substituted by 2-(3,4-dimethoxyphenyl)ethyl. A beta1 adrenoceptor antagonist, it has been shown to be as effective as other beta-blockers for the treatment of angina pectoris and hypertension. | bevantolol |
| bimatoprost | | bimatoprost |
| bisoprolol | | bisoprolol |
| bosentan anhydrous | | bosentan |
| bretylium | A quaternary ammonium cation having 2-bromobenzyl, ethyl and two methyl groups attached to the nitrogen. It blocks noradrenaline release from the peripheral sympathetic nervous system, and is used in emergency medicine, cardiology, and other specialties for the acute management of ventricular tachycardia and ventricular fibrillation. | bretylium |
| bretylium tosylate | The tosylate salt of bretylium. It blocks noradrenaline release from the peripheral sympathetic nervous system, and is used in emergency medicine, cardiology, and other specialties for the acute management of ventricular tachycardia and ventricular fibrillation. | bretylium tosylate |
| brimonidine | | brimonidine |
| camostat | A benzoate ester resulting from the formal condensation of the carboxy group of 4-guanidinobenzoic acid with the hydroxy group of 2-(dimethylamino)-2-oxoethyl (4-hydroxyphenyl)acetate. It is a potent inhibitor of the human transmembrane protease serine 2 (TMPRSS2) and its mesylate salt is currently under investigation for its effectiveness in COVID-19 patients. | camostat |
| camostat mesylate | A methanesulfonate (mesylate) salt prepared from equimolar amounts of camostat and methanesulfonic acid. It is a serine protease inhibitor approved and marketed in Japan in 1985 for the alleviation of acute symptoms associated with chronic pancreatitis. In 1994, it was approved for the treatment of postoperative reflux esophagitis. | camostat mesylate |
| candesartan | A benzimidazolecarboxylic acid that is 1H-benzimidazole-7-carboxylic acid substituted by an ethoxy group at position 2 and a ({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl) group at position 1. It is a angiotensin receptor antagonist used for the treatment of hypertension. | candesartan |
| captopril | A L-proline derivative in which L-proline is substituted on nitrogen with a (2S)-2-methyl-3-sulfanylpropanoyl group. It is used as an anti-hypertensive ACE inhibitor drug. | captopril |
| carmoxirole | An indolecarboxylic acid that is indole-5-carboxylic acid bearing an additional 4-(4-phenyl-1,2,3,6-tetrahydropyridin-1-yl)butyl substituent at position 3. Selective, peripherally acting dopamine D2 receptor agonist. Modulates noradrenalin release and sympathetic activation. Displays antihypertensive properties in vivo. | carmoxirole |
| carteolol | | carteolol |
| carteolol hydrochloride | | carteolol hydrochloride |
| carvedilol | A member of the class of carbazoles that is an adrenergic antagonist with non-selective beta- and alpha-1 receptor blocking properties which helps in the management of congestive heart failure. | carvedilol |
| cassaine | A tricyclic diterpenoid isolated from several plant species of the genus Erythrophleum. | cassaine |
| chlorothiazide | 4H-1,2,4-benzothiadiazine 1,1-dioxide in which the hydrogen at position is substituted by chlorine and that at position 7 is substituted by a sulfonamide group. A diuretic, it is used for treatment of oedema and hypertension. | chlorothiazide |
| ci 906 | A hydrochloride resulting from the reaction of equimolar amounts of quinapril and hydrogen chloride. A prodrug for quinaprilat hydrochloride (by hydrolysis of the ethyl ester to the corresponding carboxylic acid), it is used as an angiotensin-converting enzyme inhibitor (ACE inhibitor) for the treatment of hypertension and congestive heart failure. | quinapril hydrochloride |
| cilazapril, anhydrous | A pyridazinodiazepine resulting from the formal condensation of the carboxy group of cilazaprilat with ethanol. It is a drug used in the treatment of hypertension and heart failure. | cilazapril |
| cilnidipine | A diesterified 1,4-dihydropyridine-3,5-dicarboxylic acid. A calcium channel blocker, it is used as an antihypertensive. | cilnidipine |
| cleistanthin | A member of the class of cleistanthins that is the 4-O-3,4-di-O-methyl-beta-D-xylopyranoside of 1,3-dihydronaphtho[2,3-c]furan-4-ol which is substituted by an oxo group at position 1, methoxy groups at positions 6 and 7, and a 1,3-benzodioxol-5-yl group at position 9. It is one of the toxic principles in Cleistanthus collinus. | cleistanthin A |
| cleistanthin b | A member of the class of cleistanthins that is cleistanthin A in which the 3,4-di-O-methyl-D-xylopyranosyl group is replaced by a beta-D-glucopyranosyl group. | cleistanthin B |
| colforsin | A labdane diterpenoid isolated from the Indian Coleus plant. | forskolin |
| colforsin daropate | A carboxylic ester resuting from the formal condensation of the carboxy group of N,N-dimethyl-beta-alanine with the 6-hydroxy group of forskolin. It is an adenylate cyclase activator. | colforsin daropate |
| corilagin | An ellagitannin with a hexahydroxydiphenoyl group bridging over the 3-O and 6-O of the glucose core. | corilagin |
| cyclothiazide | 3,4-Dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide substituted at positions 3, 5 and 6 by a 2-norbornen-5-yl group, chlorine, and a sulfonamide group, respectively. A thiazide diuretic, it has been used in the management of hypertension and oedema. | cyclothiazide |
| debrisoquin | | debrisoquin |
| diazoxide | A benzothiadiazine that is the S,S-dioxide of 2H-1,2,4-benzothiadiazine which is substituted at position 3 by a methyl group and at position 7 by chlorine. A peripheral vasodilator, it increases the concentration of glucose in the plasma and inhibits the secretion of insulin by the beta- cells of the pancreas. It is used orally in the management of intractable hypoglycaemia and intravenously in the management of hypertensive emergencies. | diazoxide |
| diltiazem | A 5-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl acetate in which both stereocentres have S configuration. A calcium-channel blocker and vasodilator, it is used as the hydrochloride in the management of angina pectoris and hypertension. | diltiazem |
| diltiazem hydrochloride | A hydrochloride salt resulting from the reaction of equimolar amounts of diltiazem and hydrogen chloride. A calcium-channel blocker and vasodilator, it is used in the management of angina pectoris and hypertension. | diltiazem hydrochloride |
| dorzolamide | 5,6-Dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide in which hydrogens at the 4 and 6 positions are substituted by ethylamino and methyl groups, respectively (4S, trans-configuration). A carbonic anhydrase inhibitor, it is used as the hydrochloride in ophthalmic solutions to lower increased intraocular pressure in the treatment of open-angle glaucoma and ocular hypertension. | dorzolamide |
| doxazosin | A member of the class of quinazolines that is quinazoline substituted by an amino group at position 4, methoxy groups at positions 6 and 7 and a piperazin-1-yl group at position 2 which in turn is substituted by a 2,3-dihydro-1,4-benzodioxin-2-ylcarbonyl group at position 4. An antihypertensive agent, it is used in the treatment of high blood pressure. | doxazosin |
| droxidopa | A serine derivative that is L-serine substituted at the beta-position by a 3,4-dihydroxyphenyl group. A prodrug for noradrenalone, it is used for treatment of neurogenic orthostatic hypotension | droxidopa |
| enalapril | A dicarboxylic acid monoester that is ethyl 4-phenylbutanoate in which a hydrogen alpha to the carboxy group is substituted by the amino group of L-alanyl-L-proline (S-configuration). | enalapril |
| enalapril maleate | The maleic acid salt of enalapril. It contains one molecule of maleic acid for each molecule of enalapril. Following oral administration, the ethyl ester group of enalapril is hydrolysed to afford the corresponding carboxylic acid, enalaprilat, an angiotensin-converting enzyme (ACE) inhibitor. Enalapril is thus a prodrug for enalaprilat (which, unlike enalapril, is not absorbed by mouth), and its maleate is used in the treatment of hypertension and heart failure, for reduction of proteinuria and renal disease in patients with nephropathies, and for the prevention of stroke, myocardial infarction, and cardiac death in high-risk patients. | enalapril maleate |
| enalaprilat anhydrous | Enalapril in which the ethyl ester group has been hydrolysed to the corresponding carboxylic acid. Enalaprilat is an angiotensin-converting enzyme (ACE) inhibitor and is used (often in the form of its prodrug, enalapril) in the treatment of hypertension and heart failure, for reduction of proteinuria and renal disease in patients with nephropathies, and for the prevention of stroke, myocardial infarction, and cardiac death in high-risk patients. Unlike enalapril, enalaprilat is not absorbed by mouth but is given by intravenous injection, usually as the dihydrate. | enalaprilat (anhydrous) |
| enrasentan | A member of the class of indanes that is 2,3-dihydro-1H-indene which is substituted by a 1,3-benzodioxol-5-yl group, carboxy group, 2-(2-hydroxyethoxy)-4-methoxyphenyl group and a propoxy group at positions 1S, 2R, 3S and 5, respectively. It is an orally active mixed endothelin A/B receptor antagonist with a 100-fold greater affinity for the endothelin A receptor. The drug was being developed by GSK for the treatment of congestive heart failure and pulmonary hypertension (clinical trials discontinued). | enrasentan |
| eplerenone | | eplerenone |
| eprosartan | A member of the class of imidazoles and thiophenes that is an angiotensin II receptor antagonist used for the treatment of high blood pressure. | eprosartan |
| eprosartan mesylate dihydrate | | eprosartan methanesulfonate |
| fasudil | An isoquinoline substituted by a (1,4-diazepan-1-yl)sulfonyl group at position 5. It is a Rho-kinase inhibitor and its hydrochloride hydrate form is approved for the treatment of cerebral vasospasm and cerebral ischemia. | fasudil |
| fasudil hydrochloride | A hydrochloride obtained by reaction of fasudil with one equivalent of hydrochloric acid. | fasudil hydrochloride |
| felodipine | The mixed (methyl, ethyl) diester of 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid. A calcium-channel blocker, it lowers blood pressure by reducing peripheral vascular resistance through a highly selective action on smooth muscle in arteriolar resistance vessels. It is used in the management of hypertension and angina pectoris. | felodipine |
| fenoldopam | | fenoldopam |
| fluprostenol | An organofluorine compound that is racemic prostaglandin F2alpha in which the pentyl group is replaced by a 3-(trifluoromethyl)phenoxymethyl group. A synthetic analogue of prostaglandin F2alpha, ophthalmic solutions of its isopropyl ester prodrug, travoprost, are used as a topical medication for controlling the progression of open-angle glaucoma and ocular hypertension, by reducing intraocular pressure. The isopropyl ester group of travoprost is hydrolysed to the biologically active free acid by esterases in the cornea. | fluprostenol |
| forasartan | A member of the class of pyridines that is pyridine which is substituted at positions 2 and 5 by o-(tetrazol-5-yl)phenyl and (3,5-dibutyl-1,2,4-triazol-1-yl)methyl groups, respectively. It is a nonpeptide antagonist of angiotensin II, type 1 (AT1) receptors, used for the treatment of hypertension. | forasartan |
| fosinoprilat | A phosphinic acid-containing N-acyl derivative of (4S)-cyclohexyl-L-proline. An inhibitor of angiotensin converting enzyme (ACE), it is used as the phosphinate ester pro-drug fosinopril for treatment of hypertension and chronic heart failure. | fosinoprilat |
| gr 117289 | A member of the class of 1-benzofurans that is 3-bromo-1-benzofuran which is substituted by a 2-(1H-tetrazol-5-yl)phenyl group at position 2 and by a (2-butyl-5-carboxy-4-chloro-1H-imidazol-1-yl)methyl group at position 5. It is an angiotensin II receptor type 1 (AT1) antagonist and was in clinical trials for the treatment of hypertension (now discontinued). | zolasartan |
| grayanotoxin i | A tetracyclic diterpenoid that is grayanotoxane in which the pro-R hydrogen at position 14 is substituted by an acetoxy group and in which the 3beta-, 5-, 6beta-, 10-, and 16- positions are substituted by hydroxy groups. | grayanotoxin I |
| guanadrel | A spiroketal resulting from the formal condensation of the keto group of cyclohexanone with the hydroxy groups of 1-(2,3-dihydroxypropyl)guanidine. A postganglionic adrenergic blocking agent formerly used (generally as the sulfate salt) for the management of hypertension, it has been largely superseded by other drugs less likely to cause orthostatic hypotension (dizzy spells on standing up or stretching). | guanadrel |
| guanadrel sulfate | An organic sulfate salt resulting from the reaction of 2 eq. guanadrel with 1 eq. sulfuric acid. A postganglionic adrenergic blocking agent formerly used for the management of hypertension, it has been largely superseded by other drugs less likely to cause orthostatic hypotension (dizzy spells on standing up or stretching). | guanadrel sulfate |
| guanethidine | A member of the class of guanidines in which one of the hydrogens of the amino group has been replaced by a 2-azocan-1-ylethyl group. | guanethidine |
| hu 308 | A carbobicyclic compound that is bicyclo[3.1.1]hept-2-ene which is substituted by a hydroxymethyl group at position 2, a 2,6-dimethoxy-4-(2-methyloctan-2-yl)phenyl group at position 4, and two methyl groups at position 6 (the 1S,4S,5S stereoisomer). A highly selective and effective cannabinoid type-2 agonist and the enantiomer of HU-433. | HU-308 |
| hydralazine | The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent. | hydralazine |
| hydralazine hydrochloride | The hydrochloride salt of hydralazine; a direct-acting vasodilator that is used as an antihypertensive agent. | hydralazine hydrochloride |
| hydrochlorothiazide | A benzothiadiazine that is 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide substituted by a chloro group at position 6 and a sulfonamide at 7. It is diuretic used for the treatment of hypertension and congestive heart failure. | hydrochlorothiazide |
| hydroflumethiazide | A benzothiadiazine consisting of a 3,4-dihydro-HH-1,2,4-benzothiadiazine bicyclic system dioxygenated on sulfur and carrying trifluoromethyl and aminosulfonyl groups at positions 6 and 7 respectively. A diuretic with actions and uses similar to those of hydrochlorothiazide. | hydroflumethiazide |
| imidapril | A member of the class of imidazolidines that is (4S)-1-methyl-2-oxoimidazolidine-4-carboxylic acid in which the hydrogen of the imidazolidine nitrogen has been substituted by (1S)-1-{[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino}ethyl group. It is the prodrug for imidaprilat, an ACE inhibitor used for the treatment of chronic heart failure. | imidapril |
| imidaprilat | A member of the class of imidazolidines that is imidapril in which the ethyl ester group has been hydrolysed to the corresponding acid group. It is the active metabolite of imidapril used to treat hypertension. | imidaprilat |
| indapamide | A sulfonamide formed by condensation of the carboxylic group of 4-chloro-3-sulfamoylbenzoic acid with the amino group of 2-methyl-2,3-dihydro-1H-indol-1-amine. | indapamide |
| isoamyl nitrite | A nitrite ester having isopentyl as the alkyl group. | isoamyl nitrite |
| kaempferide | A monomethoxyflavone that is the 4'-O-methyl derivative of kaempferol. | kaempferide |
| ketanserin | A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group. | ketanserin |
| l 671152 | The hydrochloride salt of dorzolamide. It is used in ophthalmic solutions to lower increased intraocular pressure in the treatment of open-angle glaucoma and ocular hypertension. | dorzolamide hydrochloride |
| latanoprost | A prostaglandin Falpha that is the isopropyl ester prodrug of latanoprost free acid. Used in the treatment of open-angle glaucoma and ocular hypertension. | latanoprost |
| lisinopril | | lisinopril dihydrate |
| lofexidine | | lofexidine |
| losartan | A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position | losartan |
| macitentan | A member of the class of sulfamides in which the two amino groups of sulfonamide are substituted by 5-(4-bromophenyl)-6-{2-[(5-bromopyrimidin-2-yl)oxy]ethoxy}pyrimidin-4-yl and propyl groups. An orphan drug used for the treatment of pulmonary arterial hypertension. | macitentan |
| methyldopa | A derivative of L-tyrosine having a methyl group at the alpha-position and an additional hydroxy group at the 3-position on the phenyl ring. | alpha-methyl-L-dopa |
| metipranolol | 3-(Propan-2-ylamino)propane-1,2-diol in which the hydrogen of the primary hydroxy group is substituted by a 4-acetoxy-2,3,5-trimethylphenoxy group. A non-cardioselective beta-blocker, it is used to lower intra-ocular pressure in the management of open-angle glaucoma. | metipranolol |
| metolazone | A quinazoline that consists of 1,2,3,4-tetrahydroquinazolin-4-one bearing additional methyl, 2-tolyl, sulfamyl and chloro substituents at positions 2, 3, 6 and 7 respectively. A quinazoline diuretic, with properties similar to thiazide diuretics. | metolazone |
| metoprolol | A propanolamine that is 1-(propan-2-ylamino)propan-2-ol substituted by a 4-(2-methoxyethyl)phenoxy group at position 1. | metoprolol |
| metyrosine | An L-tyrosine derivative that consists of L-tyrosine bearing an additional methyl substituent at position 2. An inhibitor of the enzyme tyrosine 3-monooxygenase, and consequently of the synthesis of catecholamines. It is used to control the symptoms of excessive sympathetic stimulation in patients with pheochromocytoma. | alpha-methyl-L-tyrosine |
| morin | A pentahydroxyflavone that is 7-hydroxyflavonol bearing three additional hydroxy substituents at positions 2' 4' and 5. | morin |
| nimodipine | A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm. | nimodipine |
| nitrendipine | A dihydropyridine that is 1,4-dihydropyridine substituted by methyl groups at positions 2 and 6, a 3-nitrophenyl group at position 4, a ethoxycarbonyl group at position 3 and a methoxycarbonyl group at position 5. It is a calcium-channel blocker used in the treatment of hypertension. | nitrendipine |
| oleuropein | A secoiridoid glycoside that is the methyl ester of 3,4-dihydro-2H-pyran-5-carboxylic acid which is substituted at positions 2, 3, and 4 by hydroxy, ethylidene, and carboxymethyl groups, respectively and in which the anomeric hydroxy group at position 2 has been converted into its beta-D-glucoside and the carboxylic acid moiety of the carboxymethyl substituent has been converted to the corresponding 3,4-dihydroxyphenethyl ester (the 2S,3E,4S stereoisomer). The most important phenolic compound present in olive cultivars. | oleuropein |
| olmesartan | | olmesartan |
| palmidrol | An N-(long-chain-acyl)ethanolamine that is the ethanolamide of palmitic (hexadecanoic) acid. | palmitoyl ethanolamide |
| pentamethonium | A quarternary ammonium cation that is cadaverine in which the terminal amino hydrogens are substituted methyl groups. Its bromide and iodide salt exhibits ganglionic blocking activity and used in the treatment of hypertension. | pentamethonium |
| pentolinium tartrate | The bitartrate salt of pentolinium. | pentolinium tartrate |
| perindopril | An alpha-amino acid ester that is the ethyl ester of N-{(2S)-1-[(2S,3aS,7aS)-2-carboxyoctahydro-1H-indol-1-yl]-1-oxopropan-2-yl}-L-norvaline | perindopril |
| perindopril erbumine | | perindopril erbumine |
| perindoprilat | A dipeptide obtained by formal condensation of one of the carboxy groups of N-[(1S)-1-carboxyethyl]-L-norvaline with the amino group of (2S,3aS,7aS)-octahydroindole-2-carboxylic acid. The major active metabolite of perindopril. | perindoprilat |
| phxa 85 | A prostaglandin Falpha that is an analogue of prostaglandin F2alpha in which the pentyl group has been replaced by 2-phenylethyl and where the the 13,14-double bond has undergone formal hydrogenation. Its isopropyl ester prodrug, latanoprost, is used in the treatment of open-angle glaucoma and ocular hypertension. | latanoprost free acid |
| pindolol | A member of the class of indols which is the 2-hydroxy-3-(isopropylamino)propyl ether derivative of 1H-indol-4-ol. | pindolol |
| praliciguat | A member of the class of pyrazoles that is 5-fluoro-2-(1H-pyrazol-3-yl)pyrimidine which is substituted by a 2-fluorobenzyl group at position 1, 1,2-oxazol-3-yl group at position 5, and by a [3,3,3-trifluoro-2-hydroxy-2-(trifluoromethyl)propyl]nitrilo group at position 4. It is a soluble guanylate cyclase stimulator under clinical development for the treatment of heart failure with preserved ejection fraction. | praliciguat |
| pratosartan | | pratosartan |
| prazosin | A member of the class of piperazines that is piperazine substituted by a furan-2-ylcarbonyl group and a 4-amino-6,7-dimethoxyquinazolin-2-yl group at positions 1 and 4 respectively. | prazosin |
| propranolol | A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3. | propranolol |
| quinapril | A member of the class of isoquinolines that is (3S)-2-L-alanyl-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid in which the alpha-amino group of the alanyl residue has been substituted by a 1-ethoxycarbonyl-4-phenylbutan-2-yl group (the all-S isomer). A prodrug for quinaprilat (by hydrolysis of the ethyl ester to the corresponding carboxylic acid), it is used as an angiotensin-converting enzyme inhibitor (ACE inhibitor) used (generally as the hydrochloride salt) for the treatment of hypertension and congestive heart failure. | quinapril |
| quinaprilat | A dicarboxylic acid resulting from the hydrolysis of the ethyl ester group of quinapril to give the corresponding dicarboxylic acid. The active angiotensin-converting enzyme inhibitor (ACE inhibitor) of the prodrug quinapril. | quinaprilat |
| quinethazone | A member of the class of quinazolines that is quinazolin-4-one substituted at positions 2, 6 and 7 by ethyl, sulfamoyl and chloro groups respectively; a thiazide-like diuretic used to treat hypertension. | quinethazone |
| raubasine | A monoterpenoid indole alkaloid with formula C21H24N2O3, isolated from several Rauvolfia and Catharanthus species. It is a selective alpha1-adrenoceptor antagonist used for the treatment of high blood pressure. | ajmalicine |
| rescinnamine | | rescinnamine |
| reserpine | An alkaloid found in the roots of Rauwolfia serpentina and R. vomitoria. | reserpine |
| ro 42-5892 | An L-histidine derivative that is L-histidine in which one of the amino hydrogens is replaced by a (2S)-2-[(2-methylpropane-2-sulfonyl)methyl]-3-phenylpropanoyl group and the carboxy group is replaced by a [(2S,3R,4S)-1-cyclohexyl-4-cyclopropyl-3,4-dihydroxybutan-2-yl]amino group. It is a renin inhibitor which was under development for the treatment of hypertension (now discontinued). | remikiren |
| rottlerin | A chromenol that is 2,2-dimethyl-2H-chromene substituted by hydroxy groups at positions 5 and 7, a 3-acetyl-2,4,6-trihydroxy-5-methylbenzyl group at position 6 and a (1E)-3-oxo-1-phenylprop-1-en-3-yl group at position 8. A potassium channel opener, it is isolated from Mallotus philippensis. | rottlerin |
| scoparone | A member of the class of coumarins that is esculetin in which the two hydroxy groups at positions 6 and 7 are replaced by methoxy groups. It is a major constituent of the Chinese herbal medicine Yin Chen Hao, and exhibits a variety of pharmacological activities such as anti-inflammatory, anti-allergic, and anti-tumor activities. | scoparone |
| sodium nitrite | An inorganic sodium salt having nitrite as the counterion. Used as a food preservative and antidote to cyanide poisoning. | sodium nitrite |
| spirapril | | spirapril |
| spiraprilat | An azaspiro compound that is spirapril in which the ethyl ester group has been hydrolysed to the corresponding carboxylic acid group. It is the active metabolite of the angiotensin-converting enzyme (ACE) inhibitor spirapril. | spiraprilat |
| spironolactone | A steroid lactone that is 17alpha-pregn-4-ene-21,17-carbolactone substituted by an oxo group at position 3 and an alpha-acetylsulfanyl group at position 7. | spironolactone |
| tak 491 | A carboxylic ester obtained by formal condensation of the carboxy group of azilsartan with the hydroxy group of 4-(hydroxymethyl)-5-methyl-1,3-dioxol-2-one. A prodrug for azilsartan, it is used for treatment of hypertension. | azilsartan medoxomil |
| tekturna | The hemifumarate salt of aliskiren. | aliskiren fumarate |
| telmisartan | A member of the class of benzimidazoles used widely in the treatment of hypertension. | telmisartan |
| terazosin | | terazosin |
| ticrynafen | An aromatic ketone that is 2,3-dichlorophenoxyacetic acid in which the hydrogen at position 4 on the benzene ring is replaced by a thiophenecarbonyl group. A loop diuretic used to treat hypertension, it was withdrawn from the market in 1982 due to links with hepatitis. | tienilic acid |
| timolol | The (S)-(-) (more active) enantiomer of timolol. A beta-adrenergic antagonist, both the hemihydrate and the maleate salt are used in the mangement of glaucoma, hypertension, angina pectoris and myocardial infarction, and for the prevention of migraine. | (S)-timolol (anhydrous) |
| timolol maleate | The maleic acid salt of the active (S)-enantiomer of timolol, comprising equimolar amounts of (S)-timolol and maleic acid. | (S)-timolol maleate |
| tolazoline | A member of the class of imidazoles that is 4,5-dihydro-1H-imidazole substituted by a benzyl group. | tolazoline |
| torsemide | An N-sulfonylurea obtained by formal condensation of [(3-methylphenyl)amino]pyridine-3-sulfonic acid with the free amino group of N-isopropylurea. It is a potent loop diuretic used for the treatment of hypertension and edema in patients with congestive heart failure. | torasemide |
| trandolapril | A heterobicylic compound that is (2S,3aR,7aS)-1-[(2S)-2-aminopropanoyl]octahydro-1H-indole-2-carboxylic acid in which the hydrogen of the amino group is substituted by a (2R)-1-ethoxy-1-oxo-4-phenylbutan-2-yl group. It is a angiotensin-converting enzyme inhibitor and a prodrug used for the treatment of hypertension. | trandolapril |
| trandolaprilat | A heterobicyclic compound that is trandolapril in which the ethyl ester group has been hydrolysed to the corresponding acid group. It is the active metabolite of the prodrug trandolapril. | trandolaprilat |
| travoprost | The isopropyl ester of prostaglandin F2alpha in which the pentyl group is replaced by a 3-(trifluoromethyl)phenoxymethyl group. A synthetic analogue of prostaglandin F2alpha, ophthalmic solutions of travoprost are used as a topical medication for controlling the progression of open-angle glaucoma and ocular hypertension, by reducing intraocular pressure. It is a pro-drug; the isopropyl ester group is hydrolysed by esterases in the cornea to the biologically active free acid, fluprostenol. | travoprost |
| trichlormethiazide | A benzothiadiazine, hydrogenated at positions 2, 3 and 4 and substituted with an aminosulfonyl group at C-7, a chloro substituent at C-6 and a dichloromethyl group at C-3 and with S-1 as an S,S-dioxide. A sulfonamide antibiotic, it is used as a diuretic to treat oedema (including that associated with heart failure) and hypertension. | trichlormethiazide |
| trimethaphan | A complex heterocyclic sulfonium compound with an imidazolium core, used to treat hypertension. | trimethaphan |
| u 62840 | | treprostinil |
| uf 021 | The isopropyl ester of unoprostone. | isopropyl unoprostone |
| valsartan | A monocarboxylic acid amide consisting of L-valine in which the amino hydrogens have been replaced by a pentanoyl and a [2'-(1H-tetrazol-5-yl)biphenyl]-4-yl]methyl group. It exhibits antihypertensive activity. | valsartan |
| vericiguat | A pyrazolopyridine that is 5-fluoro-1H-pyrazolo[3,4-b]pyridine in which the amino hydrogen at position 1 has been substituted by a 2-fluorobenzyl group and the hydrogen at position 3 has been substituted by a 4,6-diamino-5-[(methoxycarbonyl)amino]pyrimidin-2-yl group. It is a soluble guanylate cyclase stimulator which is used for treatment of chronic heart failure. | vericiguat |
| vincamine | | vincamine |
| visnagin | A furanochromone that is furo[3,2-g]chromen-5-one which is substituted at positions 4 and 7 by methoxy and methyl groups, respectively. Found in the toothpick-plant, Ammi visnaga. | visnagin |
| Protein | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Drugs |
|---|
| 15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | Homo sapiens (human) | Potency | 27.0201 | 1 | 17 |
| 15-lipoxygenase, partial | Homo sapiens (human) | Potency | 22.6356 | 1 | 8 |
| 2,3-bisphosphoglycerate-independent phosphoglycerate mutase | Leishmania major strain Friedlin | Potency | 37.9330 | 1 | 1 |
| 67.9K protein | Vaccinia virus | Potency | 21.5316 | 2 | 9 |
| acetylcholinesterase | Homo sapiens (human) | Potency | 37.1725 | 2 | 21 |
| acid sphingomyelinase | Homo sapiens (human) | Potency | 28.3708 | 1 | 8 |
| activating transcription factor 6 | Homo sapiens (human) | Potency | 27.5392 | 1 | 8 |
| aldehyde dehydrogenase 1 family, member A1 | Homo sapiens (human) | Potency | 25.6837 | 1 | 37 |
| alpha-galactosidase | Homo sapiens (human) | Potency | 32.4730 | 2 | 14 |
| Alpha-synuclein | Homo sapiens (human) | Potency | 17.3582 | 1 | 2 |
| apical membrane antigen 1, AMA1 | Plasmodium falciparum 3D7 | Potency | 11.9939 | 1 | 3 |
| AR protein | Homo sapiens (human) | Potency | 18.8245 | 12 | 132 |
| aryl hydrocarbon receptor | Homo sapiens (human) | Potency | 20.3184 | 3 | 30 |
| arylsulfatase A | Homo sapiens (human) | Potency | 9.5965 | 1 | 18 |
| ATAD5 protein, partial | Homo sapiens (human) | Potency | 17.9288 | 4 | 29 |
| Ataxin-2 | Homo sapiens (human) | Potency | 21.3926 | 2 | 21 |
| ATP-dependent phosphofructokinase | Trypanosoma brucei brucei TREU927 | Potency | 19.1496 | 4 | 22 |
| ATPase family AAA domain-containing protein 5 | Homo sapiens (human) | Potency | 19.5630 | 2 | 18 |
| atrial natriuretic peptide receptor 1 precursor | Homo sapiens (human) | Potency | 4.2567 | 1 | 2 |
| atrial natriuretic peptide receptor 2 precursor | Homo sapiens (human) | Potency | 26.1216 | 1 | 1 |
| beta-2 adrenergic receptor | Homo sapiens (human) | Potency | 35.4813 | 1 | 1 |
| Bloom syndrome protein isoform 1 | Homo sapiens (human) | Potency | 96.4135 | 2 | 33 |
| BRCA1 | Homo sapiens (human) | Potency | 22.3872 | 1 | 1 |
| bromodomain adjacent to zinc finger domain 2B | Homo sapiens (human) | Potency | 54.4393 | 1 | 12 |
| C-terminal-binding protein 1 | Homo sapiens (human) | Potency | 16.9469 | 1 | 1 |
| caspase 7, apoptosis-related cysteine protease | Homo sapiens (human) | Potency | 50.9708 | 1 | 2 |
| caspase-1 isoform alpha precursor | Homo sapiens (human) | Potency | 23.8770 | 1 | 2 |
| caspase-3 | Cricetulus griseus (Chinese hamster) | Potency | 33.4915 | 1 | 1 |
| caspase-3 | Homo sapiens (human) | Potency | 50.9708 | 1 | 2 |
| Caspase-7 | Cricetulus griseus (Chinese hamster) | Potency | 33.4915 | 1 | 1 |
| Caspase-7 | Homo sapiens (human) | Potency | 11.8961 | 1 | 2 |
| Cellular tumor antigen p53 | Homo sapiens (human) | Potency | 19.7168 | 2 | 26 |
| cellular tumor antigen p53 isoform a | Homo sapiens (human) | Potency | 9.9173 | 2 | 9 |
| Chain A, 2-oxoglutarate Oxygenase | Homo sapiens (human) | Potency | 23.3594 | 1 | 41 |
| Chain A, ATP-DEPENDENT DNA HELICASE Q1 | Homo sapiens (human) | Potency | 22.6848 | 3 | 15 |
| Chain A, Beta-lactamase | Escherichia coli K-12 | Potency | 24.4277 | 2 | 24 |
| Chain A, Cruzipain | Trypanosoma cruzi | Potency | 35.2861 | 2 | 8 |
| Chain A, Ferritin light chain | Equus caballus (horse) | Potency | 32.6580 | 2 | 16 |
| Chain A, HADH2 protein | Homo sapiens (human) | Potency | 23.6661 | 2 | 18 |
| Chain A, JmjC domain-containing histone demethylation protein 3A | Homo sapiens (human) | Potency | 50.7752 | 1 | 8 |
| Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | Homo sapiens (human) | Potency | 10.5570 | 2 | 33 |
| Chain A, Putative fructose-1,6-bisphosphate aldolase | Giardia intestinalis | Potency | 14.1733 | 1 | 11 |
| Chain A, TYROSYL-DNA PHOSPHODIESTERASE | Homo sapiens (human) | Potency | 24.4301 | 1 | 18 |
| Chain B, HADH2 protein | Homo sapiens (human) | Potency | 23.6661 | 2 | 18 |
| chromobox protein homolog 1 | Homo sapiens (human) | Potency | 48.6482 | 2 | 34 |
| ClpP | Bacillus subtilis | Potency | 11.2202 | 1 | 1 |
| cytochrome P450 2C19 precursor | Homo sapiens (human) | Potency | 7.5506 | 1 | 2 |
| cytochrome P450 2C9 precursor | Homo sapiens (human) | Potency | 13.8144 | 1 | 9 |
| cytochrome P450 2C9, partial | Homo sapiens (human) | Potency | 14.7088 | 1 | 26 |
| cytochrome P450 2D6 | Homo sapiens (human) | Potency | 15.2275 | 1 | 29 |
| cytochrome P450 2D6 isoform 1 | Homo sapiens (human) | Potency | 14.3974 | 1 | 12 |
| cytochrome P450 3A4 isoform 1 | Homo sapiens (human) | Potency | 15.0767 | 2 | 66 |
| cytochrome P450 family 3 subfamily A polypeptide 4 | Homo sapiens (human) | Potency | 11.8781 | 2 | 40 |
| cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | Homo sapiens (human) | Potency | 19.8631 | 1 | 20 |
| D(1A) dopamine receptor | Homo sapiens (human) | Potency | 5.3661 | 3 | 19 |
| D(1A) dopamine receptor | Sus scrofa (pig) | Potency | 19.1352 | 1 | 5 |
| Disintegrin and metalloproteinase domain-containing protein 17 | Homo sapiens (human) | Potency | 10.0000 | 1 | 1 |
| DNA dC->dU-editing enzyme APOBEC-3F isoform a | Homo sapiens (human) | Potency | 17.3926 | 1 | 2 |
| DNA polymerase beta | Homo sapiens (human) | Potency | 20.1438 | 1 | 7 |
| DNA polymerase eta isoform 1 | Homo sapiens (human) | Potency | 26.9128 | 1 | 6 |
| DNA polymerase III, partial | Bacillus subtilis | Potency | 21.4849 | 1 | 3 |
| DNA polymerase iota isoform a (long) | Homo sapiens (human) | Potency | 44.3433 | 1 | 18 |
| DNA polymerase kappa isoform 1 | Homo sapiens (human) | Potency | 20.1685 | 1 | 15 |
| dopamine D1 receptor | Homo sapiens (human) | Potency | 0.0154 | 1 | 4 |
| endonuclease IV | Escherichia coli | Potency | 25.9241 | 2 | 11 |
| Endothelin receptor type B | Rattus norvegicus (Norway rat) | Potency | 12.5893 | 1 | 1 |
| Endothelin-1 receptor | Rattus norvegicus (Norway rat) | Potency | 12.5893 | 1 | 1 |
| estrogen nuclear receptor alpha | Homo sapiens (human) | Potency | 18.9473 | 12 | 153 |
| estrogen receptor 2 (ER beta) | Homo sapiens (human) | Potency | 29.7782 | 2 | 17 |
| estrogen-related nuclear receptor alpha | Homo sapiens (human) | Potency | 17.4829 | 9 | 140 |
| euchromatic histone-lysine N-methyltransferase 2 | Homo sapiens (human) | Potency | 17.2929 | 2 | 61 |
| EWS/FLI fusion protein | Homo sapiens (human) | Potency | 19.4573 | 4 | 31 |
| eyes absent homolog 2 isoform a | Homo sapiens (human) | Potency | 18.3387 | 2 | 2 |
| farnesoid X nuclear receptor | Homo sapiens (human) | Potency | 19.8222 | 5 | 24 |
| flap endonuclease 1 | Homo sapiens (human) | Potency | 22.0088 | 3 | 20 |
| Fumarate hydratase | Homo sapiens (human) | Potency | 27.8324 | 1 | 10 |
| G | Vesicular stomatitis virus | Potency | 14.7088 | 1 | 26 |
| GABA theta subunit | Rattus norvegicus (Norway rat) | Potency | 15.0767 | 1 | 33 |
| GALC protein | Homo sapiens (human) | Potency | 0.6887 | 1 | 4 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | Potency | 15.0767 | 1 | 33 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | Potency | 15.0767 | 1 | 33 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | Potency | 15.0767 | 1 | 33 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | Rattus norvegicus (Norway rat) | Potency | 15.0767 | 1 | 33 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | Rattus norvegicus (Norway rat) | Potency | 15.0767 | 1 | 33 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | Rattus norvegicus (Norway rat) | Potency | 15.0767 | 1 | 33 |
| Gamma-aminobutyric acid receptor subunit beta-1 | Rattus norvegicus (Norway rat) | Potency | 15.0767 | 1 | 33 |
| Gamma-aminobutyric acid receptor subunit beta-2 | Rattus norvegicus (Norway rat) | Potency | 15.0767 | 1 | 33 |
| Gamma-aminobutyric acid receptor subunit beta-3 | Rattus norvegicus (Norway rat) | Potency | 15.0767 | 1 | 33 |
| Gamma-aminobutyric acid receptor subunit delta | Rattus norvegicus (Norway rat) | Potency | 15.0767 | 1 | 33 |
| Gamma-aminobutyric acid receptor subunit epsilon | Rattus norvegicus (Norway rat) | Potency | 15.0767 | 1 | 33 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | Rattus norvegicus (Norway rat) | Potency | 15.0767 | 1 | 33 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | Rattus norvegicus (Norway rat) | Potency | 15.0767 | 1 | 33 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | Rattus norvegicus (Norway rat) | Potency | 15.0767 | 1 | 33 |
| Gamma-aminobutyric acid receptor subunit pi | Rattus norvegicus (Norway rat) | Potency | 15.0767 | 1 | 33 |
| geminin | Homo sapiens (human) | Potency | 12.0514 | 4 | 56 |
| GLI family zinc finger 3 | Homo sapiens (human) | Potency | 13.7201 | 2 | 55 |
| glp-1 receptor, partial | Homo sapiens (human) | Potency | 10.7928 | 3 | 14 |
| GLS protein | Homo sapiens (human) | Potency | 10.7665 | 2 | 19 |
| glucocerebrosidase | Homo sapiens (human) | Potency | 23.4999 | 1 | 10 |
| glucocorticoid receptor [Homo sapiens] | Homo sapiens (human) | Potency | 14.9797 | 5 | 37 |
| glucokinase regulatory protein | Homo sapiens (human) | Potency | 14.9763 | 1 | 2 |
| Glutamate receptor 2 | Rattus norvegicus (Norway rat) | Potency | 27.2974 | 1 | 12 |
| GTP-binding nuclear protein Ran isoform 1 | Homo sapiens (human) | Potency | 7.9667 | 1 | 3 |
| Guanine nucleotide-binding protein G | Homo sapiens (human) | Potency | 16.0097 | 2 | 5 |
| heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | Homo sapiens (human) | Potency | 26.1216 | 1 | 1 |
| heat shock protein beta-1 | Homo sapiens (human) | Potency | 38.3737 | 2 | 8 |
| hemoglobin subunit beta | Homo sapiens (human) | Potency | 22.1060 | 1 | 2 |
| hexokinase-4 isoform 1 | Homo sapiens (human) | Potency | 14.9763 | 1 | 2 |
| Histamine H2 receptor | Cavia porcellus (domestic guinea pig) | Potency | 16.4256 | 2 | 35 |
| histone acetyltransferase KAT2A isoform 1 | Homo sapiens (human) | Potency | 21.2633 | 1 | 15 |
| histone deacetylase 9 isoform 3 | Homo sapiens (human) | Potency | 14.3257 | 2 | 6 |
| Histone H2A.x | Cricetulus griseus (Chinese hamster) | Potency | 62.1003 | 2 | 10 |
| histone-lysine N-methyltransferase 2A isoform 2 precursor | Homo sapiens (human) | Potency | 49.1878 | 1 | 8 |
| HLA class I histocompatibility antigen, B alpha chain | Homo sapiens (human) | Potency | 14.7088 | 1 | 26 |
| huntingtin isoform 2 | Homo sapiens (human) | Potency | 23.2405 | 2 | 5 |
| hypothetical protein, conserved | Trypanosoma brucei | Potency | 18.5996 | 2 | 3 |
| hypoxia-inducible factor 1 alpha subunit | Homo sapiens (human) | Potency | 15.8080 | 2 | 5 |
| hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | Homo sapiens (human) | Potency | 7.8956 | 2 | 8 |
| IDH1 | Homo sapiens (human) | Potency | 19.9154 | 1 | 14 |
| importin subunit beta-1 isoform 1 | Homo sapiens (human) | Potency | 47.2699 | 2 | 7 |
| Inositol hexakisphosphate kinase 1 | Homo sapiens (human) | Potency | 14.7088 | 1 | 52 |
| Inositol monophosphatase 1 | Rattus norvegicus (Norway rat) | Potency | 4.7176 | 1 | 6 |
| Integrin alpha-IIb | Homo sapiens (human) | Potency | 11.5148 | 1 | 4 |
| Integrin beta-3 | Homo sapiens (human) | Potency | 11.5148 | 1 | 4 |
| Interferon beta | Homo sapiens (human) | Potency | 17.5218 | 3 | 35 |
| interleukin 8 | Homo sapiens (human) | Potency | 66.8242 | 1 | 1 |
| lamin isoform A-delta10 | Homo sapiens (human) | Potency | 8.9197 | 2 | 50 |
| lethal factor (plasmid) | Bacillus anthracis str. A2012 | Potency | 19.9254 | 1 | 5 |
| lethal(3)malignant brain tumor-like protein 1 isoform I | Homo sapiens (human) | Potency | 31.7626 | 1 | 3 |
| Luciferase | Photinus pyralis (common eastern firefly) | Potency | 15.2777 | 4 | 16 |
| lysosomal alpha-glucosidase preproprotein | Homo sapiens (human) | Potency | 22.9480 | 4 | 17 |
| M-phase phosphoprotein 8 | Homo sapiens (human) | Potency | 31.3592 | 1 | 17 |
| Microtubule-associated protein tau | Homo sapiens (human) | Potency | 18.3284 | 2 | 36 |
| mitogen-activated protein kinase 1 | Homo sapiens (human) | Potency | 19.6111 | 2 | 12 |
| muscarinic acetylcholine receptor M1 | Rattus norvegicus (Norway rat) | Potency | 8.2220 | 2 | 11 |
| muscleblind-like protein 1 isoform 1 | Homo sapiens (human) | Potency | 27.2252 | 1 | 5 |
| Neuronal acetylcholine receptor subunit alpha-4 | Rattus norvegicus (Norway rat) | Potency | 18.0668 | 1 | 4 |
| Neuronal acetylcholine receptor subunit beta-2 | Rattus norvegicus (Norway rat) | Potency | 18.0668 | 1 | 4 |
| neuropeptide S receptor isoform A | Homo sapiens (human) | Potency | 6.0722 | 1 | 6 |
| NFKB1 protein, partial | Homo sapiens (human) | Potency | 7.7778 | 2 | 12 |
| nonstructural protein 1 | Influenza A virus (A/WSN/1933(H1N1)) | Potency | 17.4343 | 1 | 12 |
| NPC intracellular cholesterol transporter 1 precursor | Homo sapiens (human) | Potency | 39.5629 | 1 | 3 |
| Nrf2 | Homo sapiens (human) | Potency | 15.8489 | 1 | 1 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | Homo sapiens (human) | Potency | 29.1887 | 4 | 36 |
| nuclear factor erythroid 2-related factor 2 isoform 2 | Homo sapiens (human) | Potency | 22.1817 | 1 | 8 |
| nuclear factor NF-kappa-B p105 subunit isoform 1 | Homo sapiens (human) | Potency | 42.2395 | 1 | 2 |
| nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | Homo sapiens (human) | Potency | 23.6157 | 1 | 6 |
| Nuclear receptor ROR-gamma | Homo sapiens (human) | Potency | 42.4429 | 1 | 2 |
| nuclear receptor ROR-gamma isoform 1 | Mus musculus (house mouse) | Potency | 18.2260 | 2 | 25 |
| nuclear receptor subfamily 1, group I, member 2 | Rattus norvegicus (Norway rat) | Potency | 5.0414 | 1 | 3 |
| nuclear receptor subfamily 1, group I, member 3 | Homo sapiens (human) | Potency | 22.8732 | 3 | 43 |
| Ornithine decarboxylase | Rattus norvegicus (Norway rat) | Potency | 7.9433 | 1 | 2 |
| P53 | Homo sapiens (human) | Potency | 39.8107 | 1 | 1 |
| parathyroid hormone/parathyroid hormone-related peptide receptor precursor | Homo sapiens (human) | Potency | 52.4775 | 1 | 6 |
| Parkin | Homo sapiens (human) | Potency | 10.3891 | 3 | 7 |
| peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Homo sapiens (human) | Potency | 39.9314 | 2 | 11 |
| peripheral myelin protein 22 | Rattus norvegicus (Norway rat) | Potency | 11.8231 | 2 | 19 |
| peripheral myelin protein 22 isoform 1 | Homo sapiens (human) | Potency | 59.3125 | 1 | 11 |
| peroxisome proliferator activated receptor gamma | Homo sapiens (human) | Potency | 18.9637 | 5 | 31 |
| peroxisome proliferator-activated receptor delta | Homo sapiens (human) | Potency | 26.4169 | 5 | 22 |
| phosphoglycerate kinase | Trypanosoma brucei brucei TREU927 | Potency | 13.9720 | 2 | 3 |
| phosphopantetheinyl transferase | Bacillus subtilis | Potency | 47.2954 | 3 | 17 |
| PINK1 | Homo sapiens (human) | Potency | 44.6684 | 1 | 1 |
| plasminogen precursor | Mus musculus (house mouse) | Potency | 3.5481 | 1 | 1 |
| polyprotein | Zika virus | Potency | 27.8324 | 1 | 10 |
| Polyunsaturated fatty acid lipoxygenase ALOX15B | Homo sapiens (human) | Potency | 25.2384 | 1 | 4 |
| potassium voltage-gated channel subfamily H member 2 isoform d | Homo sapiens (human) | Potency | 10.0984 | 1 | 18 |
| PPM1D protein | Homo sapiens (human) | Potency | 29.4107 | 1 | 2 |
| pregnane X nuclear receptor | Homo sapiens (human) | Potency | 19.7216 | 3 | 40 |
| pregnane X receptor | Rattus norvegicus (Norway rat) | Potency | 10.2663 | 1 | 2 |
| progesterone receptor | Homo sapiens (human) | Potency | 23.8821 | 2 | 15 |
| pyruvate kinase | Leishmania mexicana mexicana | Potency | 7.9397 | 4 | 9 |
| pyruvate kinase PKM isoform a | Homo sapiens (human) | Potency | 29.8816 | 2 | 4 |
| pyruvate kinase PKM isoform b | Homo sapiens (human) | Potency | 7.9433 | 2 | 3 |
| Rap guanine nucleotide exchange factor 3 | Homo sapiens (human) | Potency | 55.0000 | 2 | 2 |
| Rap guanine nucleotide exchange factor 4 | Homo sapiens (human) | Potency | 48.5236 | 1 | 3 |
| RAR-related orphan receptor gamma | Mus musculus (house mouse) | Potency | 19.9173 | 2 | 40 |
| ras-related protein Rab-9A | Homo sapiens (human) | Potency | 23.9054 | 1 | 3 |
| regulator of G-protein signaling 4 | Homo sapiens (human) | Potency | 11.1193 | 1 | 22 |
| relaxin receptor 1 isoform 1 | Homo sapiens (human) | Potency | 0.0388 | 1 | 1 |
| relaxin receptor 2 isoform 1 | Homo sapiens (human) | Potency | 0.0488 | 1 | 1 |
| retinoic acid nuclear receptor alpha variant 1 | Homo sapiens (human) | Potency | 25.8457 | 3 | 41 |
| retinoid X nuclear receptor alpha | Homo sapiens (human) | Potency | 23.6931 | 4 | 31 |
| serine-protein kinase ATM isoform a | Homo sapiens (human) | Potency | 17.8948 | 3 | 4 |
| serine/threonine-protein kinase mTOR isoform 1 | Homo sapiens (human) | Potency | 19.4091 | 4 | 13 |
| serine/threonine-protein kinase PLK1 | Homo sapiens (human) | Potency | 26.6795 | 1 | 1 |
| Single-stranded DNA cytosine deaminase | Homo sapiens (human) | Potency | 38.7284 | 2 | 4 |
| SMAD family member 2 | Homo sapiens (human) | Potency | 18.4100 | 2 | 12 |
| SMAD family member 3 | Homo sapiens (human) | Potency | 18.4100 | 2 | 12 |
| Smad3 | Homo sapiens (human) | Potency | 17.9981 | 1 | 12 |
| snurportin-1 | Homo sapiens (human) | Potency | 47.2699 | 2 | 7 |
| Spike glycoprotein | Severe acute respiratory syndrome-related coronavirus | Potency | 20.8582 | 1 | 27 |
| survival motor neuron protein isoform d | Homo sapiens (human) | Potency | 7.1393 | 1 | 16 |
| TAR DNA-binding protein 43 | Homo sapiens (human) | Potency | 24.5427 | 1 | 15 |
| TDP1 protein | Homo sapiens (human) | Potency | 18.2644 | 2 | 110 |
| thioredoxin glutathione reductase | Schistosoma mansoni | Potency | 16.8037 | 1 | 2 |
| thioredoxin reductase | Rattus norvegicus (Norway rat) | Potency | 23.5702 | 4 | 62 |
| Thrombopoietin | Homo sapiens (human) | Potency | 12.0007 | 2 | 10 |
| thyroid hormone receptor beta isoform 2 | Rattus norvegicus (Norway rat) | Potency | 21.7643 | 3 | 54 |
| thyroid hormone receptor beta isoform a | Homo sapiens (human) | Potency | 346.2252 | 2 | 8 |
| thyroid stimulating hormone receptor | Homo sapiens (human) | Potency | 17.6157 | 6 | 35 |
| thyrotropin-releasing hormone receptor | Homo sapiens (human) | Potency | 0.0658 | 1 | 1 |
| transcriptional regulator ERG isoform 3 | Homo sapiens (human) | Potency | 21.1998 | 1 | 3 |
| transient receptor potential cation channel subfamily V member 1 | Homo sapiens (human) | Potency | 18.3174 | 1 | 2 |
| ubiquitin carboxyl-terminal hydrolase 2 isoform a | Homo sapiens (human) | Potency | 16.9600 | 3 | 3 |
| urokinase plasminogen activator surface receptor precursor | Mus musculus (house mouse) | Potency | 3.5481 | 1 | 1 |
| urokinase-type plasminogen activator precursor | Mus musculus (house mouse) | Potency | 3.5481 | 1 | 1 |
| USP1 protein, partial | Homo sapiens (human) | Potency | 55.9072 | 3 | 24 |
| v-jun sarcoma virus 17 oncogene homolog (avian) | Homo sapiens (human) | Potency | 23.5218 | 2 | 16 |
| vitamin D (1,25- dihydroxyvitamin D3) receptor | Homo sapiens (human) | Potency | 18.6929 | 5 | 29 |
| vitamin D3 receptor isoform VDRA | Homo sapiens (human) | Potency | 44.8709 | 1 | 17 |
| Voltage-dependent calcium channel gamma-2 subunit | Mus musculus (house mouse) | Potency | 27.2974 | 1 | 12 |
| Vpr | Human immunodeficiency virus 1 | Potency | 26.6405 | 1 | 2 |
| Protein | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Drugs |
|---|
| 10 kDa chaperonin | Escherichia coli | IC50 | 70.7833 | 2 | 6 |
| 10 kDa heat shock protein, mitochondrial | Homo sapiens (human) | IC50 | 44.3333 | 1 | 3 |
| 3-oxo-5-alpha-steroid 4-dehydrogenase 2 | Homo sapiens (human) | Ki | 0.0006 | 1 | 1 |
| 3-oxoacyl-acyl-carrier protein reductase | Plasmodium falciparum (malaria parasite P. falciparum) | IC50 | 2.3000 | 1 | 1 |
| 5-hydroxytryptamine receptor 1A | Homo sapiens (human) | IC50 | 1.5507 | 3 | 3 |
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | IC50 | 0.6824 | 8 | 13 |
| 5-hydroxytryptamine receptor 1A | Homo sapiens (human) | Ki | 0.3817 | 11 | 11 |
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | Ki | 2.1142 | 7 | 17 |
| 5-hydroxytryptamine receptor 1B | Homo sapiens (human) | IC50 | 7.1706 | 3 | 3 |
| 5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | IC50 | 1.1120 | 1 | 5 |
| 5-hydroxytryptamine receptor 1B | Homo sapiens (human) | Ki | 8.3833 | 4 | 6 |
| 5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | Ki | 0.5308 | 5 | 10 |
| 5-hydroxytryptamine receptor 1D | Homo sapiens (human) | IC50 | 3.5100 | 3 | 3 |
| 5-hydroxytryptamine receptor 1D | Homo sapiens (human) | Ki | 6.6668 | 3 | 3 |
| 5-hydroxytryptamine receptor 1D | Rattus norvegicus (Norway rat) | Ki | 0.0505 | 2 | 2 |
| 5-hydroxytryptamine receptor 1F | Rattus norvegicus (Norway rat) | Ki | 0.0505 | 2 | 2 |
| 5-hydroxytryptamine receptor 2A | Homo sapiens (human) | IC50 | 0.3780 | 18 | 19 |
| 5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | IC50 | 8.4017 | 4 | 5 |
| 5-hydroxytryptamine receptor 2A | Homo sapiens (human) | Ki | 0.1036 | 13 | 15 |
| 5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | Ki | 9.9819 | 22 | 23 |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | IC50 | 1.6921 | 3 | 6 |
| 5-hydroxytryptamine receptor 2B | Rattus norvegicus (Norway rat) | IC50 | 10.5012 | 3 | 4 |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | Ki | 0.6536 | 2 | 5 |
| 5-hydroxytryptamine receptor 2B | Rattus norvegicus (Norway rat) | Ki | 20.8698 | 10 | 11 |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | IC50 | 1.5935 | 3 | 5 |
| 5-hydroxytryptamine receptor 2C | Rattus norvegicus (Norway rat) | IC50 | 10.5012 | 3 | 4 |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | Ki | 9.2818 | 3 | 6 |
| 5-hydroxytryptamine receptor 2C | Rattus norvegicus (Norway rat) | Ki | 17.9860 | 12 | 13 |
| 5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | IC50 | 0.9843 | 1 | 3 |
| 5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | Ki | 0.5157 | 1 | 3 |
| 5-hydroxytryptamine receptor 5A | Homo sapiens (human) | Ki | 20.0000 | 2 | 2 |
| 5-hydroxytryptamine receptor 6 | Homo sapiens (human) | IC50 | 3.1235 | 2 | 4 |
| 5-hydroxytryptamine receptor 6 | Homo sapiens (human) | Ki | 1.5685 | 2 | 4 |
| 5-hydroxytryptamine receptor 7 | Cavia porcellus (domestic guinea pig) | IC50 | 27.3000 | 1 | 8 |
| 5-hydroxytryptamine receptor 7 | Homo sapiens (human) | IC50 | 5.0119 | 1 | 1 |
| 5-hydroxytryptamine receptor 7 | Cavia porcellus (domestic guinea pig) | Ki | 0.0035 | 1 | 1 |
| 5-hydroxytryptamine receptor 7 | Homo sapiens (human) | Ki | 1.2965 | 2 | 2 |
| 5-hydroxytryptamine receptor 7 | Rattus norvegicus (Norway rat) | Ki | 0.0035 | 1 | 1 |
| 60 kDa chaperonin | Escherichia coli K-12 | IC50 | 250.0000 | 1 | 3 |
| 60 kDa chaperonin | Escherichia coli | IC50 | 70.7833 | 2 | 6 |
| 60 kDa heat shock protein, mitochondrial | Homo sapiens (human) | IC50 | 44.3333 | 1 | 3 |
| Acetylcholinesterase | Homo sapiens (human) | IC50 | 0.0180 | 1 | 1 |
| Acetylcholinesterase | Tetronarce californica (Pacific electric ray) | IC50 | 40.0000 | 1 | 1 |
| Acyl carrier protein, mitochondrial | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| Adenosine receptor A2a | Homo sapiens (human) | IC50 | 5.0119 | 1 | 1 |
| Adenosine receptor A2a | Rattus norvegicus (Norway rat) | IC50 | 0.0032 | 1 | 1 |
| Adenosine receptor A2a | Rattus norvegicus (Norway rat) | Ki | 33.6500 | 1 | 2 |
| Adenosine receptor A3 | Homo sapiens (human) | IC50 | 2.4296 | 2 | 3 |
| Adenosine receptor A3 | Homo sapiens (human) | Ki | 18.6761 | 3 | 6 |
| Adenylate cyclase type 1 | Homo sapiens (human) | IC50 | 0.0955 | 2 | 2 |
| Albumin | Homo sapiens (human) | Ki | 2,290,870,000.0000 | 1 | 1 |
| Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | IC50 | 1.8016 | 1 | 2 |
| Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | Ki | 1.7864 | 1 | 2 |
| Alpha-1A adrenergic receptor | Homo sapiens (human) | IC50 | 0.6590 | 7 | 8 |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | IC50 | 6.1413 | 11 | 17 |
| Alpha-1A adrenergic receptor | Bos taurus (cattle) | Ki | 1.3847 | 5 | 19 |
| Alpha-1A adrenergic receptor | Homo sapiens (human) | Ki | 0.0762 | 28 | 46 |
| Alpha-1A adrenergic receptor | Oryctolagus cuniculus (rabbit) | Ki | 0.0133 | 1 | 4 |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | Ki | 0.0984 | 17 | 23 |
| Alpha-1B adrenergic receptor | Homo sapiens (human) | IC50 | 0.0372 | 6 | 7 |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | IC50 | 5.8001 | 12 | 18 |
| Alpha-1B adrenergic receptor | Homo sapiens (human) | Ki | 0.2166 | 26 | 40 |
| Alpha-1B adrenergic receptor | Mesocricetus auratus (golden hamster) | Ki | 0.0008 | 2 | 2 |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | Ki | 0.0868 | 20 | 26 |
| Alpha-1D adrenergic receptor | Homo sapiens (human) | IC50 | 0.1542 | 8 | 13 |
| Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | IC50 | 7.2946 | 9 | 14 |
| Alpha-1D adrenergic receptor | Homo sapiens (human) | Ki | 0.1643 | 26 | 42 |
| Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | Ki | 0.0299 | 16 | 38 |
| Alpha-2A adrenergic receptor | Homo sapiens (human) | IC50 | 3.2130 | 3 | 7 |
| Alpha-2A adrenergic receptor | Bos taurus (cattle) | Ki | 0.1060 | 1 | 1 |
| Alpha-2A adrenergic receptor | Homo sapiens (human) | Ki | 0.9852 | 20 | 28 |
| Alpha-2A adrenergic receptor | Mus musculus (house mouse) | Ki | 0.2276 | 5 | 10 |
| Alpha-2A adrenergic receptor | Rattus norvegicus (Norway rat) | Ki | 1.3834 | 19 | 25 |
| Alpha-2A adrenergic receptor | Sus scrofa (pig) | Ki | 4.1000 | 1 | 1 |
| Alpha-2B adrenergic receptor | Homo sapiens (human) | IC50 | 0.9508 | 2 | 6 |
| Alpha-2B adrenergic receptor | Homo sapiens (human) | Ki | 0.7762 | 18 | 26 |
| Alpha-2B adrenergic receptor | Mus musculus (house mouse) | Ki | 0.2276 | 5 | 10 |
| Alpha-2B adrenergic receptor | Rattus norvegicus (Norway rat) | Ki | 1.2683 | 20 | 26 |
| Alpha-2C adrenergic receptor | Homo sapiens (human) | IC50 | 2.2656 | 3 | 6 |
| Alpha-2C adrenergic receptor | Homo sapiens (human) | Ki | 0.5219 | 21 | 27 |
| Alpha-2C adrenergic receptor | Mus musculus (house mouse) | Ki | 0.2276 | 5 | 10 |
| Alpha-2C adrenergic receptor | Rattus norvegicus (Norway rat) | Ki | 1.3715 | 18 | 24 |
| Amine oxidase [flavin-containing] A | Homo sapiens (human) | IC50 | 0.1900 | 1 | 1 |
| Amine oxidase [flavin-containing] A | Mus musculus (house mouse) | IC50 | 0.0000 | 1 | 1 |
| Amine oxidase [flavin-containing] B | Mus musculus (house mouse) | IC50 | 0.3000 | 2 | 2 |
| Amyloid-beta precursor protein | Homo sapiens (human) | IC50 | 24.7750 | 4 | 4 |
| Androgen receptor | Homo sapiens (human) | IC50 | 5.7680 | 7 | 12 |
| Androgen receptor | Rattus norvegicus (Norway rat) | IC50 | 16.2250 | 2 | 3 |
| Androgen receptor | Homo sapiens (human) | Ki | 0.0394 | 1 | 1 |
| Androgen receptor | Rattus norvegicus (Norway rat) | Ki | 0.0508 | 2 | 2 |
| Angiotensin-converting enzyme | Mus musculus (house mouse) | IC50 | 0.0115 | 1 | 1 |
| Angiotensin-converting enzyme | Oryctolagus cuniculus (rabbit) | IC50 | 1.3982 | 16 | 28 |
| Angiotensin-converting enzyme | Rattus norvegicus (Norway rat) | IC50 | 0.0628 | 13 | 18 |
| Angiotensin-converting enzyme | Oryctolagus cuniculus (rabbit) | Ki | 3.5856 | 3 | 8 |
| Angiotensin-converting enzyme | Rattus norvegicus (Norway rat) | Ki | 1.3875 | 3 | 8 |
| Angiotensin-converting enzyme | Homo sapiens (human) | IC50 | 59.9781 | 33 | 66 |
| Angiotensin-converting enzyme | Homo sapiens (human) | Ki | 2.0012 | 2 | 3 |
| Angiotensin-converting enzyme 2 | Rattus norvegicus (Norway rat) | Ki | 0.0005 | 1 | 1 |
| Angiotensin-converting enzyme 2 | Homo sapiens (human) | IC50 | 0.0293 | 2 | 6 |
| Apelin receptor | Homo sapiens (human) | Ki | 0.0007 | 1 | 1 |
| Aspartate aminotransferase, cytoplasmic | Homo sapiens (human) | IC50 | 26.6200 | 2 | 2 |
| Aspartate aminotransferase, cytoplasmic | Homo sapiens (human) | Ki | 17.4700 | 2 | 2 |
| ATP-binding cassette sub-family C member 3 | Homo sapiens (human) | IC50 | 121.5071 | 1 | 35 |
| ATP-binding cassette sub-family C member 8 | Homo sapiens (human) | IC50 | 470.5000 | 4 | 4 |
| ATP-dependent translocase ABCB1 | Homo sapiens (human) | IC50 | 96.3131 | 15 | 28 |
| ATP-dependent translocase ABCB1 | Homo sapiens (human) | Ki | 39.2971 | 6 | 7 |
| ATP-dependent translocase ABCB1 | Mus musculus (house mouse) | Ki | 10.9650 | 2 | 2 |
| ATP-sensitive inward rectifier potassium channel 11 | Homo sapiens (human) | IC50 | 470.5000 | 4 | 4 |
| Atrial natriuretic peptide receptor 3 | Homo sapiens (human) | IC50 | 0.0018 | 1 | 1 |
| Aurora kinase B | Homo sapiens (human) | IC50 | 4.7100 | 1 | 1 |
| B2 bradykinin receptor | Cavia porcellus (domestic guinea pig) | IC50 | 1.2000 | 1 | 1 |
| Beta-1 adrenergic receptor | Homo sapiens (human) | IC50 | 0.3287 | 16 | 22 |
| Beta-1 adrenergic receptor | Rattus norvegicus (Norway rat) | IC50 | 0.0120 | 2 | 3 |
| Beta-1 adrenergic receptor | Homo sapiens (human) | Ki | 0.1911 | 9 | 19 |
| Beta-1 adrenergic receptor | Mus musculus (house mouse) | Ki | 0.0189 | 1 | 3 |
| Beta-1 adrenergic receptor | Rattus norvegicus (Norway rat) | Ki | 0.8031 | 7 | 17 |
| Beta-1 adrenergic receptor | Cavia porcellus (domestic guinea pig) | IC50 | 0.0347 | 1 | 1 |
| Beta-2 adrenergic receptor | Canis lupus familiaris (dog) | IC50 | 0.0170 | 1 | 1 |
| Beta-2 adrenergic receptor | Cavia porcellus (domestic guinea pig) | IC50 | 0.0288 | 1 | 1 |
| Beta-2 adrenergic receptor | Homo sapiens (human) | IC50 | 1.2523 | 10 | 16 |
| Beta-2 adrenergic receptor | Rattus norvegicus (Norway rat) | IC50 | 0.0120 | 2 | 3 |
| Beta-2 adrenergic receptor | Homo sapiens (human) | Ki | 1.1876 | 9 | 20 |
| Beta-2 adrenergic receptor | Rattus norvegicus (Norway rat) | Ki | 1.6000 | 1 | 1 |
| Beta-3 adrenergic receptor | Homo sapiens (human) | IC50 | 0.6243 | 4 | 8 |
| Beta-3 adrenergic receptor | Rattus norvegicus (Norway rat) | IC50 | 0.0120 | 2 | 3 |
| Beta-3 adrenergic receptor | Homo sapiens (human) | Ki | 0.7414 | 1 | 5 |
| Beta-3 adrenergic receptor | Rattus norvegicus (Norway rat) | Ki | 1.6000 | 1 | 1 |
| Beta-carbonic anhydrase 1 | Mycobacterium tuberculosis H37Rv | Ki | 0.7440 | 3 | 3 |
| Beta-casein | Rattus norvegicus (Norway rat) | Ki | 0.0004 | 1 | 1 |
| Beta-hydroxyacyl-ACP dehydratase precursor (Fatty acid synthesis protein) | Plasmodium falciparum (malaria parasite P. falciparum) | IC50 | 8.0000 | 1 | 1 |
| Beta-lactamase | Enterobacter cloacae | IC50 | 119.0000 | 2 | 2 |
| Beta-lactamase | Escherichia coli K-12 | IC50 | 25.0000 | 4 | 4 |
| Beta-lactamase | Bacillus anthracis | IC50 | 25.8000 | 1 | 1 |
| Beta-lactamase | Pseudomonas aeruginosa | IC50 | 5.0000 | 1 | 1 |
| Beta-lactamase | Bacillus anthracis | Ki | 17.9000 | 1 | 1 |
| Beta-lactamase | Pseudomonas aeruginosa | Ki | 2.4000 | 1 | 1 |
| Beta-lactamase class B VIM-2 | Pseudomonas aeruginosa | IC50 | 3.5000 | 1 | 1 |
| Beta-lactamase TEM | Escherichia coli | Ki | 300.0000 | 1 | 1 |
| Beta-secretase 1 | Homo sapiens (human) | IC50 | 285.8000 | 2 | 3 |
| Bile acid receptor | Homo sapiens (human) | IC50 | 6.9600 | 1 | 2 |
| Bile salt export pump | Homo sapiens (human) | IC50 | 239.1215 | 9 | 89 |
| Bile salt export pump | Rattus norvegicus (Norway rat) | IC50 | 676.8667 | 1 | 3 |
| Bile salt export pump | Rattus norvegicus (Norway rat) | Ki | 12.0000 | 1 | 1 |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | IC50 | 105.8541 | 9 | 10 |
| Bromodomain-containing protein 2 | Homo sapiens (human) | IC50 | 0.0009 | 1 | 1 |
| Bromodomain-containing protein 2 | Homo sapiens (human) | Ki | 0.0006 | 1 | 1 |
| C-C chemokine receptor type 2 | Homo sapiens (human) | IC50 | 35.0000 | 2 | 2 |
| C-C motif chemokine 2 | Homo sapiens (human) | IC50 | 6.9183 | 1 | 1 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | Homo sapiens (human) | IC50 | 1.5465 | 1 | 2 |
| cAMP-dependent protein kinase catalytic subunit alpha | Bos taurus (cattle) | IC50 | 1.8042 | 1 | 12 |
| cAMP-dependent protein kinase catalytic subunit alpha | Homo sapiens (human) | IC50 | 4.5800 | 1 | 1 |
| cAMP-dependent protein kinase catalytic subunit alpha | Homo sapiens (human) | Ki | 0.4600 | 1 | 1 |
| cAMP-dependent protein kinase catalytic subunit alpha | Mus musculus (house mouse) | Ki | 0.4950 | 1 | 2 |
| cAMP-dependent protein kinase catalytic subunit beta | Homo sapiens (human) | IC50 | 4.5800 | 1 | 1 |
| cAMP-dependent protein kinase catalytic subunit beta | Homo sapiens (human) | Ki | 0.4600 | 1 | 1 |
| cAMP-dependent protein kinase catalytic subunit gamma | Homo sapiens (human) | IC50 | 4.5800 | 1 | 1 |
| cAMP-dependent protein kinase catalytic subunit gamma | Homo sapiens (human) | Ki | 0.4600 | 1 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4A | Homo sapiens (human) | IC50 | 26.0000 | 1 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4B | Homo sapiens (human) | IC50 | 26.0000 | 1 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4C | Homo sapiens (human) | IC50 | 26.0000 | 1 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Homo sapiens (human) | IC50 | 16.5750 | 2 | 2 |
| Canalicular multispecific organic anion transporter 1 | Homo sapiens (human) | IC50 | 128.1828 | 1 | 29 |
| Canalicular multispecific organic anion transporter 1 | Homo sapiens (human) | Ki | 295.0000 | 1 | 1 |
| Cannabinoid receptor 1 | Homo sapiens (human) | IC50 | 1.7360 | 1 | 1 |
| Cannabinoid receptor 1 | Homo sapiens (human) | Ki | 4.0928 | 3 | 4 |
| Cannabinoid receptor 1 | Rattus norvegicus (Norway rat) | Ki | 10.0000 | 2 | 2 |
| Cannabinoid receptor 2 | Homo sapiens (human) | Ki | 1.6803 | 8 | 9 |
| Carbonic anhydrase | Candida albicans SC5314 | Ki | 2.7520 | 3 | 4 |
| Carbonic anhydrase | Helicobacter pylori 26695 | Ki | 4.3350 | 2 | 2 |
| Carbonic anhydrase | Methanosarcina thermophila | Ki | 4,080.4240 | 5 | 5 |
| Carbonic anhydrase | Methanothermobacter thermautotrophicus str. Delta H | Ki | 30.7000 | 1 | 1 |
| Carbonic anhydrase | Saccharomyces cerevisiae S288C | Ki | 0.1100 | 1 | 1 |
| Carbonic anhydrase | Stylophora pistillata | Ki | 0.1130 | 1 | 1 |
| Carbonic anhydrase | Anopheles gambiae (African malaria mosquito) | Ki | 0.1532 | 1 | 2 |
| Carbonic anhydrase | Astrosclera willeyana | Ki | 21,266.8913 | 2 | 3 |
| Carbonic anhydrase | Cryptococcus neoformans var. grubii | Ki | 8.3470 | 1 | 1 |
| Carbonic anhydrase | Mycobacterium tuberculosis H37Rv | Ki | 0.1370 | 1 | 1 |
| Carbonic anhydrase | Nakaseomyces glabratus CBS 138 | Ki | 6.6350 | 1 | 1 |
| Carbonic anhydrase | Pseudomonas aeruginosa PAO1 | Ki | 940.0000 | 1 | 1 |
| Carbonic anhydrase | Stylophora pistillata | Ki | 0.0181 | 2 | 2 |
| Carbonic anhydrase | Sulfurihydrogenibium sp. YO3AOP1 | Ki | 0.0076 | 1 | 2 |
| Carbonic anhydrase 1 | Homo sapiens (human) | IC50 | 50.0000 | 1 | 1 |
| Carbonic anhydrase 1 | Homo sapiens (human) | Ki | 223,230,931.4151 | 98 | 224 |
| Carbonic anhydrase 12 | Homo sapiens (human) | Ki | 487.8262 | 25 | 118 |
| Carbonic anhydrase 13 | Homo sapiens (human) | Ki | 0.0180 | 1 | 1 |
| Carbonic anhydrase 13 | Mus musculus (house mouse) | Ki | 31.2306 | 10 | 96 |
| Carbonic anhydrase 14 | Homo sapiens (human) | Ki | 31.0691 | 11 | 97 |
| Carbonic anhydrase 15 | Mus musculus (house mouse) | Ki | 0.0440 | 2 | 3 |
| Carbonic anhydrase 2 | Homo sapiens (human) | IC50 | 27,995,384,615.8149 | 9 | 13 |
| Carbonic anhydrase 2 | Homo sapiens (human) | Ki | 5,089.6116 | 123 | 256 |
| Carbonic anhydrase 2 | Mycobacterium tuberculosis H37Rv | Ki | 0.0990 | 1 | 1 |
| Carbonic anhydrase 3 | Bos taurus (cattle) | Ki | 13.5500 | 1 | 4 |
| Carbonic anhydrase 3 | Homo sapiens (human) | Ki | 73.3480 | 8 | 94 |
| Carbonic anhydrase 4 | Bos taurus (cattle) | IC50 | 0.0430 | 1 | 1 |
| Carbonic anhydrase 4 | Homo sapiens (human) | IC50 | 0.0262 | 2 | 3 |
| Carbonic anhydrase 4 | Bos taurus (cattle) | Ki | 1,800,368.0360 | 19 | 25 |
| Carbonic anhydrase 4 | Homo sapiens (human) | Ki | 326.0755 | 15 | 104 |
| Carbonic anhydrase 5A, mitochondrial | Homo sapiens (human) | Ki | 191.9224 | 11 | 99 |
| Carbonic anhydrase 5A, mitochondrial | Mus musculus (house mouse) | Ki | 12.5250 | 1 | 4 |
| Carbonic anhydrase 5B, mitochondrial | Homo sapiens (human) | Ki | 30.5896 | 10 | 98 |
| Carbonic anhydrase 6 | Homo sapiens (human) | Ki | 30.3534 | 12 | 99 |
| Carbonic anhydrase 7 | Homo sapiens (human) | Ki | 29.6710 | 14 | 101 |
| Carbonic anhydrase 9 | Homo sapiens (human) | IC50 | 0.0520 | 1 | 1 |
| Carbonic anhydrase 9 | Homo sapiens (human) | Ki | 418.2375 | 39 | 138 |
| Carbonic anhydrase, alpha family | Hydrogenovibrio crunogenus XCL-2 | Ki | 0.1515 | 1 | 2 |
| Casein kinase II subunit alpha | Homo sapiens (human) | IC50 | 10.0000 | 2 | 2 |
| Casein kinase II subunit alpha 3 | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
| Casein kinase II subunit alpha' | Homo sapiens (human) | IC50 | 10.0000 | 2 | 2 |
| Casein kinase II subunit beta | Homo sapiens (human) | IC50 | 10.0000 | 2 | 2 |
| Cathepsin B | Homo sapiens (human) | IC50 | 50.0000 | 1 | 1 |
| Cathepsin D | Bos taurus (cattle) | IC50 | 100.0000 | 1 | 1 |
| Cathepsin G | Homo sapiens (human) | IC50 | 100.0000 | 1 | 1 |
| Cationic trypsin | Bos taurus (cattle) | IC50 | 110.8000 | 1 | 1 |
| Cell division control protein 42 homolog | Homo sapiens (human) | IC50 | 6.5000 | 2 | 2 |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase A | Homo sapiens (human) | IC50 | 13.0000 | 1 | 1 |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase B | Homo sapiens (human) | IC50 | 13.0000 | 1 | 1 |
| Chain A, angiotensin converting enzyme | Drosophila melanogaster (fruit fly) | Ki | 0.0011 | 1 | 2 |
| Chain A, cAMP-dependent protein kinase, alpha-catalytic subunit | Bos taurus (cattle) | IC50 | 2.2800 | 1 | 5 |
| Chain A, CARBONIC ANHYDRASE II | Homo sapiens (human) | Ki | 0.0004 | 1 | 3 |
| Chain A, Mineralocorticoid receptor | Homo sapiens (human) | IC50 | 0.0490 | 1 | 2 |
| Chain A, Rho-associated protein kinase 1 | Homo sapiens (human) | Ki | 0.5300 | 1 | 3 |
| Chain B, Rho-associated protein kinase 1 | Homo sapiens (human) | Ki | 0.5300 | 1 | 1 |
| Chain E, cAMP-dependent protein kinase, alpha-catalytic subunit | Mus musculus (house mouse) | Ki | 0.5300 | 1 | 1 |
| Chain I, cAMP-dependent protein kinase inhibitor alpha | synthetic construct | IC50 | 2.2800 | 1 | 2 |
| Chain I, cAMP-dependent protein kinase inhibitor, alpha form | synthetic construct | Ki | 0.5300 | 1 | 1 |
| Cholecystokinin receptor type A | Homo sapiens (human) | IC50 | 5.0119 | 1 | 1 |
| Chromaffin granule amine transporter | Homo sapiens (human) | IC50 | 0.0500 | 2 | 2 |
| Chymotrypsinogen A | Bos taurus (cattle) | IC50 | 112.6667 | 3 | 3 |
| Chymotrypsinogen B | Homo sapiens (human) | IC50 | 25.0000 | 1 | 1 |
| Class A sortase SrtA | Staphylococcus aureus | IC50 | 31.2600 | 3 | 3 |
| Coagulation factor VII | Homo sapiens (human) | IC50 | 740.0000 | 1 | 1 |
| Collagenase ColH | Hathewaya histolytica | IC50 | 0.0240 | 1 | 1 |
| Complex I intermediate-associated protein 30, mitochondrial | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| Corticotropin-releasing factor receptor 2 | Homo sapiens (human) | Ki | 5.0000 | 1 | 1 |
| Cystathionine gamma-lyase | Homo sapiens (human) | IC50 | 3,000.0000 | 1 | 1 |
| Cytochrome c oxidase subunit NDUFA4 | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| Cytochrome P450 1A1 | Homo sapiens (human) | IC50 | 0.1940 | 2 | 2 |
| Cytochrome P450 1A2 | Homo sapiens (human) | IC50 | 4.3772 | 4 | 4 |
| Cytochrome P450 1B1 | Homo sapiens (human) | IC50 | 0.3770 | 3 | 3 |
| Cytochrome P450 2C19 | Homo sapiens (human) | IC50 | 5.0000 | 2 | 4 |
| Cytochrome P450 2C8 | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
| Cytochrome P450 2C9 | Homo sapiens (human) | IC50 | 18.2459 | 4 | 16 |
| Cytochrome P450 2C9 | Homo sapiens (human) | Ki | 7.6500 | 2 | 2 |
| Cytochrome P450 2D1 | Rattus norvegicus (Norway rat) | IC50 | 529.0000 | 1 | 1 |
| Cytochrome P450 2D26 | Rattus norvegicus (Norway rat) | IC50 | 107.0000 | 1 | 1 |
| Cytochrome P450 2D3 | Rattus norvegicus (Norway rat) | IC50 | 1,754.0000 | 1 | 1 |
| Cytochrome P450 2D4 | Rattus norvegicus (Norway rat) | IC50 | 747.0000 | 1 | 1 |
| Cytochrome P450 2D6 | Homo sapiens (human) | IC50 | 30.0890 | 5 | 8 |
| Cytochrome P450 2D6 | Homo sapiens (human) | Ki | 0.0045 | 2 | 2 |
| Cytochrome P450 2J2 | Homo sapiens (human) | IC50 | 24.6591 | 3 | 11 |
| Cytochrome P450 2J2 | Homo sapiens (human) | Ki | 0.1450 | 2 | 2 |
| Cytochrome P450 3A4 | Homo sapiens (human) | IC50 | 47.6214 | 4 | 5 |
| Cytochrome P450 3A4 | Homo sapiens (human) | Ki | 1.3500 | 2 | 2 |
| D | Rattus norvegicus (Norway rat) | Ki | 3.9606 | 3 | 5 |
| D(1A) dopamine receptor | Homo sapiens (human) | IC50 | 3.2549 | 2 | 2 |
| D(1A) dopamine receptor | Homo sapiens (human) | Ki | 0.2763 | 2 | 3 |
| D(2) dopamine receptor | Bos taurus (cattle) | IC50 | 1.5800 | 1 | 2 |
| D(2) dopamine receptor | Homo sapiens (human) | IC50 | 2.5789 | 2 | 2 |
| D(2) dopamine receptor | Rattus norvegicus (Norway rat) | IC50 | 4.8667 | 2 | 3 |
| D(2) dopamine receptor | Bos taurus (cattle) | Ki | 0.7900 | 1 | 1 |
| D(2) dopamine receptor | Homo sapiens (human) | Ki | 0.2756 | 4 | 4 |
| D(2) dopamine receptor | Rattus norvegicus (Norway rat) | Ki | 3.8513 | 3 | 3 |
| D(3) dopamine receptor | Homo sapiens (human) | IC50 | 0.5770 | 1 | 1 |
| D(3) dopamine receptor | Homo sapiens (human) | Ki | 3.6480 | 2 | 2 |
| D(3) dopamine receptor | Rattus norvegicus (Norway rat) | Ki | 5.0000 | 1 | 1 |
| D(4) dopamine receptor | Homo sapiens (human) | Ki | 4.1518 | 2 | 2 |
| Death-associated protein kinase 1 | Homo sapiens (human) | IC50 | 6.3000 | 2 | 2 |
| Delta carbonic anhydrase | Conticribra weissflogii | Ki | 2.1598 | 1 | 2 |
| Delta-type opioid receptor | Homo sapiens (human) | IC50 | 5.0119 | 1 | 1 |
| Delta-type opioid receptor | Mus musculus (house mouse) | Ki | 12.6568 | 2 | 4 |
| Delta-type opioid receptor | Rattus norvegicus (Norway rat) | Ki | 0.0999 | 2 | 3 |
| Deoxyhypusine synthase | Homo sapiens (human) | IC50 | 60.8300 | 1 | 1 |
| Dipeptidyl peptidase 3 | Homo sapiens (human) | IC50 | 85.0000 | 1 | 1 |
| Dipeptidyl peptidase 4 | Homo sapiens (human) | IC50 | 100.0000 | 1 | 1 |
| DNA repair protein RAD52 homolog | Homo sapiens (human) | IC50 | 1.0000 | 2 | 2 |
| DNA topoisomerase 1 | Homo sapiens (human) | IC50 | 100.0000 | 2 | 2 |
| DNA-3-methyladenine glycosylase | Homo sapiens (human) | IC50 | 2.6000 | 1 | 1 |
| EEF1AKMT4-ECE2 readthrough transcript protein | Homo sapiens (human) | Ki | 100.0000 | 1 | 1 |
| Endothelin receptor type B | Homo sapiens (human) | IC50 | 0.4895 | 9 | 12 |
| Endothelin receptor type B | Rattus norvegicus (Norway rat) | IC50 | 0.4910 | 2 | 3 |
| Endothelin receptor type B | Homo sapiens (human) | Ki | 0.1602 | 3 | 4 |
| Endothelin-1 receptor | Homo sapiens (human) | IC50 | 0.4912 | 11 | 14 |
| Endothelin-1 receptor | Rattus norvegicus (Norway rat) | IC50 | 0.0047 | 1 | 1 |
| Endothelin-1 receptor | Sus scrofa (pig) | IC50 | 0.0075 | 1 | 1 |
| Endothelin-1 receptor | Homo sapiens (human) | Ki | 2.8595 | 6 | 7 |
| Endothelin-1 receptor | Rattus norvegicus (Norway rat) | Ki | 0.0065 | 1 | 1 |
| Endothelin-converting enzyme 1 | Homo sapiens (human) | Ki | 5.2505 | 2 | 4 |
| Enoyl-acyl-carrier protein reductase | Plasmodium falciparum (malaria parasite P. falciparum) | IC50 | 5.0000 | 1 | 1 |
| Epidermal growth factor receptor | Homo sapiens (human) | IC50 | 4.2524 | 1 | 2 |
| Estrogen receptor | Homo sapiens (human) | IC50 | 13.9255 | 2 | 4 |
| Estrogen receptor | Homo sapiens (human) | Ki | 1.1000 | 1 | 1 |
| Estrogen receptor beta | Homo sapiens (human) | IC50 | 52.0000 | 3 | 5 |
| estrogen receptor beta isoform 1 | Homo sapiens (human) | IC50 | 18.6181 | 2 | 3 |
| Eukaryotic elongation factor 2 kinase | Homo sapiens (human) | IC50 | 5.3000 | 1 | 1 |
| Fatty acid-binding protein, liver | Rattus norvegicus (Norway rat) | Ki | 717.0000 | 1 | 1 |
| Fatty-acid amide hydrolase 1 | Rattus norvegicus (Norway rat) | IC50 | 5.0119 | 1 | 1 |
| fructose-bisphosphate aldolase | Mycobacterium tuberculosis H37Rv | IC50 | 9.9910 | 1 | 1 |
| Furin | Homo sapiens (human) | IC50 | 0.0180 | 1 | 1 |
| Furin | Homo sapiens (human) | Ki | 3.4394 | 1 | 6 |
| G-protein coupled receptor 35 | Homo sapiens (human) | IC50 | 1.6000 | 1 | 1 |
| G-protein coupled receptor 55 | Homo sapiens (human) | IC50 | 1.4652 | 1 | 1 |
| GABA theta subunit | Rattus norvegicus (Norway rat) | IC50 | 0.0288 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | IC50 | 0.0288 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | IC50 | 0.0288 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | IC50 | 0.0288 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | Rattus norvegicus (Norway rat) | IC50 | 0.0288 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | Rattus norvegicus (Norway rat) | IC50 | 0.0288 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | Rattus norvegicus (Norway rat) | IC50 | 0.0288 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit beta-1 | Rattus norvegicus (Norway rat) | IC50 | 0.0288 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit beta-2 | Rattus norvegicus (Norway rat) | IC50 | 0.0288 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit beta-3 | Rattus norvegicus (Norway rat) | IC50 | 0.0288 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit delta | Rattus norvegicus (Norway rat) | IC50 | 0.0288 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit epsilon | Rattus norvegicus (Norway rat) | IC50 | 0.0288 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | Rattus norvegicus (Norway rat) | IC50 | 0.0288 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | Rattus norvegicus (Norway rat) | IC50 | 0.0288 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | Rattus norvegicus (Norway rat) | IC50 | 0.0288 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit pi | Rattus norvegicus (Norway rat) | IC50 | 0.0288 | 1 | 2 |
| Glucocorticoid receptor | Homo sapiens (human) | IC50 | 12.3458 | 5 | 9 |
| Glucocorticoid receptor | Homo sapiens (human) | Ki | 1.3532 | 3 | 3 |
| Glycine receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | IC50 | 1.9025 | 1 | 1 |
| Glycine receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | Ki | 0.8648 | 1 | 1 |
| Glycine receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | IC50 | 1.9025 | 1 | 1 |
| Glycine receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | Ki | 0.8648 | 1 | 1 |
| Glycine receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | IC50 | 1.9025 | 1 | 1 |
| Glycine receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | Ki | 0.8648 | 1 | 1 |
| Glycine receptor subunit beta | Rattus norvegicus (Norway rat) | IC50 | 1.9025 | 1 | 1 |
| Glycine receptor subunit beta | Rattus norvegicus (Norway rat) | Ki | 0.8648 | 1 | 1 |
| Hepatocyte growth factor activator | Homo sapiens (human) | IC50 | 32.0000 | 1 | 1 |
| Histamine H1 receptor | Cavia porcellus (domestic guinea pig) | Ki | 0.0100 | 1 | 1 |
| Histamine H1 receptor | Homo sapiens (human) | Ki | 0.0020 | 1 | 1 |
| Histone-lysine N-methyltransferase SETD7 | Homo sapiens (human) | IC50 | 103.0100 | 1 | 2 |
| Induced myeloid leukemia cell differentiation protein Mcl-1 | Homo sapiens (human) | IC50 | 25.1400 | 1 | 1 |
| Induced myeloid leukemia cell differentiation protein Mcl-1 | Homo sapiens (human) | Ki | 9.5400 | 1 | 1 |
| Integrase | Human immunodeficiency virus 1 | IC50 | 54.1000 | 2 | 2 |
| Interstitial collagenase | Homo sapiens (human) | IC50 | 4.8783 | 2 | 3 |
| Islet amyloid polypeptide | Homo sapiens (human) | IC50 | 7.8000 | 1 | 1 |
| Kallikrein-1 | Homo sapiens (human) | IC50 | 34.1000 | 1 | 1 |
| Kappa-type opioid receptor | Homo sapiens (human) | IC50 | 5.0119 | 1 | 1 |
| Lactoperoxidase | Bos taurus (cattle) | IC50 | 1.2000 | 1 | 1 |
| Lactoylglutathione lyase | Homo sapiens (human) | Ki | 30.1995 | 1 | 1 |
| Lanosterol 14-alpha demethylase | Rattus norvegicus (Norway rat) | Ki | 0.0057 | 1 | 1 |
| Lethal factor | Bacillus anthracis | IC50 | 4.8000 | 1 | 1 |
| Leukotriene A-4 hydrolase | Cavia porcellus (domestic guinea pig) | IC50 | 630.0000 | 1 | 1 |
| Leukotriene A-4 hydrolase | Homo sapiens (human) | IC50 | 8.8000 | 2 | 2 |
| Leukotriene A-4 hydrolase | Homo sapiens (human) | Ki | 3.7000 | 1 | 1 |
| Low molecular weight phosphotyrosine protein phosphatase | Bos taurus (cattle) | IC50 | 10.0000 | 1 | 1 |
| Lysine-specific demethylase 4E | Homo sapiens (human) | Ki | 1.9200 | 1 | 1 |
| M-phase inducer phosphatase 1 | Homo sapiens (human) | IC50 | 20.0000 | 1 | 1 |
| Malate dehydrogenase | Thermus thermophilus | IC50 | 0.7000 | 1 | 1 |
| MAP kinase-activated protein kinase 2 | Homo sapiens (human) | IC50 | 5.4000 | 1 | 1 |
| MAP kinase-activated protein kinase 5 | Homo sapiens (human) | IC50 | 1.9000 | 2 | 2 |
| Matrix metalloproteinase-9 | Homo sapiens (human) | IC50 | 6.9630 | 1 | 1 |
| Mcl-1 | Homo sapiens (human) | IC50 | 2.9883 | 1 | 1 |
| Melatonin receptor type 1A | Homo sapiens (human) | Ki | 1.9000 | 1 | 1 |
| Metallo-beta-lactamase type 2 | Klebsiella pneumoniae | IC50 | 49.9594 | 1 | 2 |
| microphthalmia-associated transcription factor isoform 9 | Homo sapiens (human) | IC50 | 6.3810 | 3 | 3 |
| Mineralocorticoid receptor | Rattus norvegicus (Norway rat) | IC50 | 0.0398 | 1 | 1 |
| Mineralocorticoid receptor | Rattus norvegicus (Norway rat) | Ki | 0.0444 | 1 | 1 |
| Mineralocorticoid receptor | Homo sapiens (human) | IC50 | 0.3827 | 18 | 29 |
| Mineralocorticoid receptor | Homo sapiens (human) | Ki | 0.0444 | 2 | 3 |
| Mitogen-activated protein kinase 10 | Homo sapiens (human) | IC50 | 30.9000 | 1 | 4 |
| Mitogen-activated protein kinase 14 | Homo sapiens (human) | IC50 | 30.9000 | 1 | 4 |
| MO15-related protein kinase Pfmrk | Plasmodium falciparum (malaria parasite P. falciparum) | IC50 | 500.0000 | 1 | 1 |
| MPI protein | Homo sapiens (human) | IC50 | 50.0000 | 1 | 2 |
| Mu-type opioid receptor | Homo sapiens (human) | IC50 | 4.5819 | 2 | 2 |
| Mu-type opioid receptor | Cavia porcellus (domestic guinea pig) | Ki | 0.1495 | 1 | 2 |
| Mu-type opioid receptor | Homo sapiens (human) | Ki | 1.6860 | 1 | 1 |
| Mu-type opioid receptor | Rattus norvegicus (Norway rat) | Ki | 21,016.7760 | 2 | 3 |
| Multidrug and toxin extrusion protein 1 | Homo sapiens (human) | IC50 | 172.9250 | 1 | 8 |
| Multidrug and toxin extrusion protein 2 | Homo sapiens (human) | IC50 | 25.5500 | 1 | 2 |
| Multidrug resistance-associated protein 4 | Homo sapiens (human) | IC50 | 117.7571 | 1 | 35 |
| Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | IC50 | 5.0119 | 1 | 1 |
| Muscarinic acetylcholine receptor M2 | Homo sapiens (human) | IC50 | 5.0119 | 1 | 1 |
| Muscarinic acetylcholine receptor M3 | Homo sapiens (human) | IC50 | 5.0119 | 1 | 1 |
| Myeloperoxidase | Homo sapiens (human) | IC50 | 1.2650 | 4 | 4 |
| Myosin light chain kinase, smooth muscle | Homo sapiens (human) | IC50 | 12.6000 | 2 | 2 |
| Myosin light chain kinase, smooth muscle | Homo sapiens (human) | Ki | 36.0000 | 1 | 1 |
| Myotonin-protein kinase | Homo sapiens (human) | IC50 | 8.0000 | 1 | 1 |
| N-glycosylase/DNA lyase | Homo sapiens (human) | IC50 | 50.0000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 2 | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 3 | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 4 | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1 | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10, mitochondrial | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 11 | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 12 | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13 | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 2 | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 3 | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 4-like 2 | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5 | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6 | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 7 | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 8 | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 9, mitochondrial | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 1 | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 10 | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 11, mitochondrial | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 2, mitochondrial | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 3 | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 4 | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 5, mitochondrial | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 6 | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7 | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 8, mitochondrial | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 9 | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] 1 subunit C1, mitochondrial | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] 1 subunit C2 | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] flavoprotein 2, mitochondrial | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] flavoprotein 3, mitochondrial | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, mitochondrial | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] iron-sulfur protein 5 | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] iron-sulfur protein 7, mitochondrial | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] iron-sulfur protein 8, mitochondrial | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH-ubiquinone oxidoreductase chain 1 | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH-ubiquinone oxidoreductase chain 2 | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH-ubiquinone oxidoreductase chain 3 | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH-ubiquinone oxidoreductase chain 4 | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH-ubiquinone oxidoreductase chain 4L | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH-ubiquinone oxidoreductase chain 5 | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH-ubiquinone oxidoreductase chain 6 | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NEDD8-activating enzyme E1 regulatory subunit isoform a | Homo sapiens (human) | IC50 | 34.7000 | 1 | 1 |
| NEDD8-conjugating enzyme Ubc12 | Homo sapiens (human) | IC50 | 34.7000 | 1 | 1 |
| Neprilysin | Homo sapiens (human) | IC50 | 420.0000 | 2 | 2 |
| Neprilysin | Oryctolagus cuniculus (rabbit) | Ki | 3.0005 | 2 | 4 |
| Neutrophil elastase | Homo sapiens (human) | IC50 | 100.0000 | 1 | 1 |
| Nischarin | Rattus norvegicus (Norway rat) | Ki | 0.0056 | 1 | 1 |
| Nuclear factor NF-kappa-B p100 subunit | Homo sapiens (human) | IC50 | 24.0000 | 1 | 1 |
| Nuclear factor NF-kappa-B p105 subunit | Homo sapiens (human) | IC50 | 24.0000 | 1 | 1 |
| nuclear receptor subfamily 0 group B member 1 | Homo sapiens (human) | IC50 | 1.7290 | 1 | 1 |
| Nuclear receptor subfamily 3 group C member 3 | Bos taurus (cattle) | IC50 | 10.2042 | 1 | 3 |
| Nuclear receptor subfamily 3 group C member 3 | Bos taurus (cattle) | Ki | 8.3601 | 1 | 3 |
| Pancreatic triacylglycerol lipase | Sus scrofa (pig) | IC50 | 100.0000 | 1 | 1 |
| Pepsin A | Sus scrofa (pig) | IC50 | 100.0000 | 1 | 1 |
| Peroxisome proliferator-activated receptor alpha | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
| Peroxisome proliferator-activated receptor delta | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
| Peroxisome proliferator-activated receptor gamma | Homo sapiens (human) | IC50 | 12.2000 | 1 | 1 |
| Plasminogen | Rattus norvegicus (Norway rat) | IC50 | 2.6200 | 1 | 1 |
| Platelet glycoprotein VI | Homo sapiens (human) | IC50 | 4.0000 | 2 | 2 |
| Platelet-activating factor receptor | Homo sapiens (human) | IC50 | 0.0003 | 1 | 1 |
| Platelet-activating factor receptor | Cavia porcellus (domestic guinea pig) | Ki | 73.3100 | 1 | 1 |
| Platelet-activating factor receptor | Homo sapiens (human) | Ki | 0.0001 | 1 | 1 |
| Polyphenol oxidase 2 | Agaricus bisporus | IC50 | 100.0000 | 1 | 1 |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | Homo sapiens (human) | IC50 | 23.9000 | 1 | 1 |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | Oryctolagus cuniculus (rabbit) | IC50 | 2.8977 | 1 | 3 |
| Potassium channel subfamily K member 10 | Homo sapiens (human) | IC50 | 15.8000 | 2 | 2 |
| Potassium channel subfamily K member 2 | Homo sapiens (human) | IC50 | 7.4333 | 3 | 3 |
| Potassium channel subfamily K member 2 | Bos taurus (cattle) | IC50 | 0.4300 | 1 | 1 |
| Potassium voltage-gated channel subfamily A member 1 | Homo sapiens (human) | IC50 | 144.0000 | 1 | 1 |
| Potassium voltage-gated channel subfamily D member 3 | Homo sapiens (human) | IC50 | 1,000.0000 | 1 | 1 |
| Potassium voltage-gated channel subfamily E member 1 | Homo sapiens (human) | IC50 | 125.8930 | 1 | 1 |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | IC50 | 16.1392 | 18 | 39 |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | Ki | 7.3026 | 5 | 7 |
| Potassium voltage-gated channel subfamily KQT member 1 | Homo sapiens (human) | IC50 | 125.8930 | 1 | 1 |
| Procathepsin L | Homo sapiens (human) | IC50 | 0.0180 | 1 | 1 |
| Procathepsin L | Homo sapiens (human) | Ki | 3.4394 | 1 | 6 |
| procathepsin L isoform 1 preproprotein | Homo sapiens (human) | IC50 | 50.0000 | 1 | 1 |
| Progesterone receptor | Homo sapiens (human) | IC50 | 7.6700 | 5 | 10 |
| Progesterone receptor | Homo sapiens (human) | Ki | 10.1762 | 2 | 2 |
| Prostaglandin G/H synthase 1 | Homo sapiens (human) | Ki | 17.0000 | 1 | 1 |
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | Ki | 12.0000 | 1 | 1 |
| Protease | Human immunodeficiency virus 1 | Ki | 0.0765 | 1 | 1 |
| Protein E6 | Human papillomavirus 16 | IC50 | 4.0000 | 1 | 1 |
| Protein kinase C alpha type | Homo sapiens (human) | IC50 | 20.0000 | 1 | 1 |
| Protein kinase C alpha type | Rattus norvegicus (Norway rat) | IC50 | 20.0000 | 1 | 2 |
| Protein kinase C beta type | Rattus norvegicus (Norway rat) | IC50 | 20.0000 | 1 | 2 |
| Protein kinase C delta type | Homo sapiens (human) | IC50 | 3.0000 | 2 | 2 |
| Protein kinase C delta type | Rattus norvegicus (Norway rat) | IC50 | 20.0000 | 1 | 2 |
| Protein kinase C epsilon type | Homo sapiens (human) | IC50 | 3.0000 | 2 | 2 |
| Protein kinase C epsilon type | Rattus norvegicus (Norway rat) | IC50 | 20.0000 | 1 | 2 |
| Protein kinase C eta type | Rattus norvegicus (Norway rat) | IC50 | 20.0000 | 1 | 2 |
| Protein kinase C gamma type | Rattus norvegicus (Norway rat) | IC50 | 20.0000 | 1 | 2 |
| Protein kinase C theta type | Rattus norvegicus (Norway rat) | IC50 | 20.0000 | 1 | 2 |
| Protein kinase C zeta type | Rattus norvegicus (Norway rat) | IC50 | 20.0000 | 1 | 2 |
| Protein-glutamine gamma-glutamyltransferase 2 | Homo sapiens (human) | IC50 | 20.0000 | 1 | 1 |
| Prothrombin | Homo sapiens (human) | IC50 | 10.7993 | 3 | 3 |
| Prothrombin | Homo sapiens (human) | Ki | 2.9549 | 2 | 7 |
| Quinolone resistance protein NorA | Staphylococcus aureus | IC50 | 8.5429 | 7 | 7 |
| Receptor protein-tyrosine kinase | Homo sapiens (human) | IC50 | 20.0000 | 1 | 1 |
| Receptor tyrosine-protein kinase erbB-2 | Homo sapiens (human) | IC50 | 5.9472 | 1 | 1 |
| Receptor-type tyrosine-protein phosphatase eta | Homo sapiens (human) | IC50 | 20.0000 | 1 | 1 |
| Receptor-type tyrosine-protein phosphatase S | Homo sapiens (human) | IC50 | 4.3000 | 1 | 1 |
| Renin | Homo sapiens (human) | IC50 | 0.0010 | 25 | 26 |
| Renin | Macaca mulatta (Rhesus monkey) | IC50 | 0.0012 | 1 | 1 |
| Renin | Homo sapiens (human) | Ki | 0.0012 | 2 | 2 |
| Renin | Oryctolagus cuniculus (rabbit) | IC50 | 0.0110 | 1 | 1 |
| Renin | Rattus norvegicus (Norway rat) | IC50 | 0.0840 | 2 | 2 |
| Renin-1 | Mus musculus (house mouse) | IC50 | 0.0045 | 1 | 1 |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | IC50 | 35.0000 | 2 | 2 |
| Rho-associated protein kinase 1 | Homo sapiens (human) | IC50 | 1.0502 | 10 | 10 |
| Rho-associated protein kinase 1 | Homo sapiens (human) | Ki | 0.4300 | 6 | 7 |
| Rho-associated protein kinase 2 | Bos taurus (cattle) | IC50 | 1.8042 | 1 | 12 |
| Rho-associated protein kinase 2 | Homo sapiens (human) | IC50 | 1.3060 | 14 | 14 |
| Rho-associated protein kinase 2 | Rattus norvegicus (Norway rat) | IC50 | 1.9000 | 1 | 1 |
| Rho-associated protein kinase 2 | Homo sapiens (human) | Ki | 0.3300 | 1 | 1 |
| Ribosomal protein S6 kinase alpha-5 | Homo sapiens (human) | IC50 | 5.0000 | 1 | 1 |
| Ribosyldihydronicotinamide dehydrogenase [quinone] | Homo sapiens (human) | IC50 | 0.0078 | 1 | 1 |
| RNA-directed RNA polymerase | | IC50 | 20.0000 | 1 | 1 |
| RuvB-like 1 | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
| Serine protease hepsin | Homo sapiens (human) | IC50 | 0.0235 | 2 | 2 |
| Serine protease hepsin | Homo sapiens (human) | Ki | 3.4394 | 1 | 6 |
| Serine/threonine-protein kinase N1 | Homo sapiens (human) | IC50 | 1.7000 | 1 | 1 |
| Serine/threonine-protein kinase N2 | Homo sapiens (human) | IC50 | 1.8533 | 3 | 3 |
| Serine/threonine-protein kinase pim-1 | Homo sapiens (human) | IC50 | 2.7000 | 1 | 1 |
| Serine/threonine-protein kinase PLK1 | Homo sapiens (human) | IC50 | 12.6000 | 1 | 1 |
| Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | IC50 | 1.4355 | 2 | 2 |
| Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | Ki | 1.2060 | 1 | 1 |
| Sodium channel protein type 1 subunit alpha | Homo sapiens (human) | IC50 | 22.5000 | 2 | 2 |
| Sodium channel protein type 10 subunit alpha | Homo sapiens (human) | IC50 | 22.5000 | 2 | 2 |
| Sodium channel protein type 11 subunit alpha | Homo sapiens (human) | IC50 | 22.5000 | 2 | 2 |
| Sodium channel protein type 2 subunit alpha | Homo sapiens (human) | IC50 | 22.5000 | 2 | 2 |
| Sodium channel protein type 3 subunit alpha | Homo sapiens (human) | IC50 | 22.5000 | 2 | 2 |
| Sodium channel protein type 4 subunit alpha | Homo sapiens (human) | IC50 | 22.5000 | 2 | 2 |
| Sodium channel protein type 5 subunit alpha | Homo sapiens (human) | IC50 | 305.8693 | 6 | 6 |
| Sodium channel protein type 7 subunit alpha | Homo sapiens (human) | IC50 | 22.5000 | 2 | 2 |
| Sodium channel protein type 8 subunit alpha | Homo sapiens (human) | IC50 | 22.5000 | 2 | 2 |
| Sodium channel protein type 9 subunit alpha | Homo sapiens (human) | IC50 | 22.5000 | 2 | 2 |
| Sodium-dependent dopamine transporter | Homo sapiens (human) | IC50 | 2.1847 | 1 | 3 |
| Sodium-dependent dopamine transporter | Homo sapiens (human) | Ki | 1.7357 | 1 | 3 |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | IC50 | 1.8016 | 1 | 2 |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | Ki | 4.5243 | 2 | 3 |
| Sodium-dependent serotonin transporter | Homo sapiens (human) | IC50 | 1.0963 | 1 | 3 |
| Sodium-dependent serotonin transporter | Rattus norvegicus (Norway rat) | IC50 | 7.9300 | 1 | 2 |
| Sodium-dependent serotonin transporter | Homo sapiens (human) | Ki | 2.9370 | 2 | 4 |
| Sodium-dependent serotonin transporter | Rattus norvegicus (Norway rat) | Ki | 7.0000 | 1 | 1 |
| Sodium/bile acid cotransporter | Homo sapiens (human) | IC50 | 10,008.8750 | 4 | 4 |
| Sodium/bile acid cotransporter | Homo sapiens (human) | Ki | 11.9000 | 1 | 1 |
| Solute carrier family 15 member 1 | Homo sapiens (human) | IC50 | 57,033.3333 | 2 | 3 |
| Solute carrier family 15 member 1 | Rattus norvegicus (Norway rat) | Ki | 6,500.0000 | 1 | 2 |
| Solute carrier family 22 member 1 | Rattus norvegicus (Norway rat) | Ki | 20.0000 | 1 | 1 |
| Solute carrier family 22 member 1 | Homo sapiens (human) | IC50 | 18.4729 | 3 | 7 |
| Solute carrier family 22 member 1 | Homo sapiens (human) | Ki | 95.8000 | 1 | 1 |
| Solute carrier family 22 member 12 | Homo sapiens (human) | IC50 | 2.0000 | 1 | 1 |
| Solute carrier family 22 member 12 | Rattus norvegicus (Norway rat) | IC50 | 18.0000 | 1 | 1 |
| Solute carrier family 22 member 12 | Homo sapiens (human) | Ki | 5.7400 | 1 | 1 |
| Solute carrier family 22 member 2 | Homo sapiens (human) | IC50 | 34.4000 | 2 | 4 |
| Solute carrier family 22 member 3 | Homo sapiens (human) | IC50 | 12.6000 | 1 | 1 |
| Solute carrier family 22 member 6 | Rattus norvegicus (Norway rat) | Ki | 150.0000 | 1 | 1 |
| Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | IC50 | 1.0752 | 1 | 2 |
| Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | Ki | 0.5950 | 1 | 2 |
| Solute carrier organic anion transporter family member 1B3 | Homo sapiens (human) | IC50 | 1.2035 | 1 | 2 |
| Solute carrier organic anion transporter family member 1B3 | Homo sapiens (human) | Ki | 0.9250 | 1 | 2 |
| Solute carrier organic anion transporter family member 2A1 | Homo sapiens (human) | Ki | 5.0745 | 1 | 2 |
| Sortase A | Streptococcus mutans | IC50 | 27.2000 | 1 | 1 |
| Squalene monooxygenase | Rattus norvegicus (Norway rat) | IC50 | 4.0000 | 1 | 1 |
| Squalene synthase | Rattus norvegicus (Norway rat) | IC50 | 4.2000 | 1 | 1 |
| Squalene synthase | Rattus norvegicus (Norway rat) | Ki | 6.6683 | 2 | 3 |
| steroidogenic factor 1 | Homo sapiens (human) | IC50 | 67.5470 | 1 | 1 |
| Stromal cell-derived factor 1 | Homo sapiens (human) | IC50 | 15.0000 | 1 | 1 |
| Succinyl-diaminopimelate desuccinylase | Haemophilus influenzae Rd KW20 | IC50 | 501.6500 | 1 | 2 |
| Succinyl-diaminopimelate desuccinylase | Haemophilus influenzae Rd KW20 | Ki | 1.8200 | 1 | 1 |
| Synaptic vesicular amine transporter | Homo sapiens (human) | IC50 | 0.0560 | 3 | 4 |
| Synaptic vesicular amine transporter | Rattus norvegicus (Norway rat) | IC50 | 0.0177 | 1 | 10 |
| Synaptic vesicular amine transporter | Bos taurus (cattle) | Ki | 0.0010 | 1 | 1 |
| Synaptic vesicular amine transporter | Homo sapiens (human) | Ki | 0.4442 | 3 | 6 |
| Thiosulfate sulfurtransferase | Homo sapiens (human) | IC50 | 85.6667 | 1 | 3 |
| Thromboxane A2 receptor | Homo sapiens (human) | IC50 | 20.0000 | 1 | 1 |
| Thromboxane-A synthase | Homo sapiens (human) | IC50 | 501.5297 | 2 | 2 |
| Tissue factor | Homo sapiens (human) | IC50 | 740.0000 | 1 | 1 |
| Toll-like receptor 4 | Homo sapiens (human) | IC50 | 32.2200 | 1 | 1 |
| Trace amine-associated receptor 1 | Homo sapiens (human) | Ki | 1.6400 | 1 | 1 |
| Transcription factor p65 | Homo sapiens (human) | IC50 | 24.0000 | 1 | 1 |
| Transient receptor potential cation channel subfamily V member 2 | Rattus norvegicus (Norway rat) | IC50 | 10.0000 | 2 | 2 |
| Transmembrane protease serine 2 | Homo sapiens (human) | IC50 | 0.0180 | 1 | 1 |
| Transmembrane protease serine 2 | Homo sapiens (human) | Ki | 3.4394 | 1 | 6 |
| Transmembrane protease serine 6 | Homo sapiens (human) | IC50 | 0.0180 | 1 | 1 |
| Transmembrane protease serine 6 | Homo sapiens (human) | Ki | 3.4394 | 1 | 6 |
| Trypsin-1 | Homo sapiens (human) | IC50 | 0.0270 | 2 | 2 |
| Trypsin-2 | Homo sapiens (human) | IC50 | 0.0035 | 1 | 1 |
| Trypsin-3 | Homo sapiens (human) | IC50 | 0.0035 | 1 | 1 |
| Type-1 angiotensin II receptor | Cavia porcellus (domestic guinea pig) | IC50 | 0.0180 | 1 | 1 |
| Type-1 angiotensin II receptor | Homo sapiens (human) | IC50 | 0.1967 | 23 | 30 |
| Type-1 angiotensin II receptor | Oryctolagus cuniculus (rabbit) | IC50 | 0.0250 | 2 | 2 |
| Type-1 angiotensin II receptor | Homo sapiens (human) | Ki | 0.3661 | 11 | 13 |
| Type-1 angiotensin II receptor | Oryctolagus cuniculus (rabbit) | Ki | 1.5678 | 4 | 6 |
| Type-1A angiotensin II receptor | Rattus norvegicus (Norway rat) | IC50 | 0.0368 | 18 | 21 |
| Type-1A angiotensin II receptor | Rattus norvegicus (Norway rat) | Ki | 0.0132 | 5 | 8 |
| Type-1B angiotensin II receptor | Rattus norvegicus (Norway rat) | IC50 | 1.3162 | 23 | 28 |
| Type-1B angiotensin II receptor | Rattus norvegicus (Norway rat) | Ki | 0.0192 | 7 | 10 |
| Type-2 angiotensin II receptor | Homo sapiens (human) | IC50 | 5.7175 | 6 | 7 |
| Type-2 angiotensin II receptor | Rattus norvegicus (Norway rat) | IC50 | 17.3531 | 11 | 13 |
| Type-2 angiotensin II receptor | Homo sapiens (human) | Ki | 10.0000 | 2 | 2 |
| Type-2 angiotensin II receptor | Rattus norvegicus (Norway rat) | Ki | 0.0316 | 1 | 1 |
| Tyrosine-protein kinase Fyn | Homo sapiens (human) | IC50 | 5.1760 | 1 | 1 |
| Tyrosine-protein kinase JAK3 | Homo sapiens (human) | IC50 | 20.0000 | 1 | 1 |
| Tyrosine-protein kinase SYK | Homo sapiens (human) | IC50 | 28.0000 | 1 | 1 |
| Tyrosine-protein kinase Yes | Homo sapiens (human) | Ki | 7.9000 | 1 | 1 |
| tyrosine-protein phosphatase non-receptor type 7 isoform 2 | Homo sapiens (human) | IC50 | 100.0000 | 1 | 1 |
| Ubiquitin carboxyl-terminal hydrolase 1 | Homo sapiens (human) | IC50 | 8.0000 | 1 | 1 |
| ubiquitin-conjugating enzyme E2 N | Homo sapiens (human) | IC50 | 20.0000 | 1 | 1 |
| UDP-glucuronosyltransferase 1A1 | Homo sapiens (human) | IC50 | 19.5000 | 2 | 2 |
| Urease | Canavalia ensiformis (jack bean) | IC50 | 64.3600 | 1 | 1 |
| Vasopressin V1a receptor | Homo sapiens (human) | IC50 | 5.0119 | 1 | 1 |
| Vesicular acetylcholine transporter | Rattus norvegicus (Norway rat) | Ki | 10.0000 | 1 | 1 |
| Voltage-dependent calcium channel gamma-1 subunit | Homo sapiens (human) | IC50 | 14.0000 | 1 | 1 |
| Voltage-dependent calcium channel gamma-2 subunit | Homo sapiens (human) | IC50 | 14.0000 | 1 | 1 |
| Voltage-dependent calcium channel gamma-3 subunit | Homo sapiens (human) | IC50 | 14.0000 | 1 | 1 |
| Voltage-dependent calcium channel gamma-4 subunit | Homo sapiens (human) | IC50 | 14.0000 | 1 | 1 |
| Voltage-dependent calcium channel gamma-5 subunit | Homo sapiens (human) | IC50 | 14.0000 | 1 | 1 |
| Voltage-dependent calcium channel gamma-6 subunit | Homo sapiens (human) | IC50 | 14.0000 | 1 | 1 |
| Voltage-dependent calcium channel gamma-7 subunit | Homo sapiens (human) | IC50 | 14.0000 | 1 | 1 |
| Voltage-dependent calcium channel gamma-8 subunit | Homo sapiens (human) | IC50 | 14.0000 | 1 | 1 |
| Voltage-dependent calcium channel subunit alpha-2/delta-1 | Homo sapiens (human) | IC50 | 7.0149 | 2 | 2 |
| Voltage-dependent calcium channel subunit alpha-2/delta-2 | Homo sapiens (human) | IC50 | 14.0000 | 1 | 1 |
| Voltage-dependent calcium channel subunit alpha-2/delta-3 | Homo sapiens (human) | IC50 | 14.0000 | 1 | 1 |
| Voltage-dependent calcium channel subunit alpha-2/delta-4 | Homo sapiens (human) | IC50 | 14.0000 | 1 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | Cavia porcellus (domestic guinea pig) | IC50 | 9.4114 | 7 | 14 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | Homo sapiens (human) | IC50 | 19.1066 | 16 | 16 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | Rattus norvegicus (Norway rat) | IC50 | 12.0536 | 8 | 11 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | Homo sapiens (human) | Ki | 0.0002 | 1 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | Rattus norvegicus (Norway rat) | Ki | 0.0998 | 4 | 4 |
| Voltage-dependent L-type calcium channel subunit alpha-1D | Rattus norvegicus (Norway rat) | IC50 | 1.5379 | 5 | 5 |
| Voltage-dependent L-type calcium channel subunit alpha-1D | Rattus norvegicus (Norway rat) | Ki | 0.0585 | 2 | 2 |
| Voltage-dependent L-type calcium channel subunit alpha-1D | Homo sapiens (human) | IC50 | 2.7067 | 6 | 6 |
| Voltage-dependent L-type calcium channel subunit alpha-1F | Homo sapiens (human) | IC50 | 2.7067 | 6 | 6 |
| Voltage-dependent L-type calcium channel subunit alpha-1S | Homo sapiens (human) | IC50 | 2.7067 | 6 | 6 |
| Voltage-dependent L-type calcium channel subunit alpha-1S | Rattus norvegicus (Norway rat) | IC50 | 1.5379 | 5 | 5 |
| Voltage-dependent L-type calcium channel subunit alpha-1S | Rattus norvegicus (Norway rat) | Ki | 0.0585 | 2 | 2 |
| Voltage-dependent L-type calcium channel subunit beta-1 | Homo sapiens (human) | IC50 | 14.0000 | 1 | 1 |
| Voltage-dependent L-type calcium channel subunit beta-2 | Homo sapiens (human) | IC50 | 7.0149 | 2 | 2 |
| Voltage-dependent L-type calcium channel subunit beta-3 | Homo sapiens (human) | IC50 | 14.0000 | 1 | 1 |
| Voltage-dependent L-type calcium channel subunit beta-4 | Homo sapiens (human) | IC50 | 14.0000 | 1 | 1 |
| Voltage-dependent N-type calcium channel subunit alpha-1B | Homo sapiens (human) | IC50 | 16.9000 | 4 | 4 |
| Voltage-dependent P/Q-type calcium channel subunit alpha-1A | Homo sapiens (human) | IC50 | 14.0000 | 1 | 1 |
| Voltage-dependent R-type calcium channel subunit alpha-1E | Homo sapiens (human) | IC50 | 14.0000 | 1 | 1 |
| Voltage-dependent T-type calcium channel subunit alpha-1G | Homo sapiens (human) | IC50 | 14.0000 | 1 | 1 |
| Voltage-dependent T-type calcium channel subunit alpha-1H | Homo sapiens (human) | IC50 | 19.0000 | 2 | 2 |
| Voltage-dependent T-type calcium channel subunit alpha-1I | Homo sapiens (human) | IC50 | 14.0000 | 1 | 1 |
| WD repeat-containing protein 48 | Homo sapiens (human) | IC50 | 8.0000 | 1 | 1 |
| Xanthine dehydrogenase/oxidase | Bos taurus (cattle) | IC50 | 224.5000 | 2 | 2 |
| Xanthine dehydrogenase/oxidase | Homo sapiens (human) | IC50 | 10.1000 | 1 | 1 |
| Protein | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Drugs |
|---|
| 26S proteasome regulatory subunit 6B | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| 5-hydroxytryptamine receptor 1A | Homo sapiens (human) | EC50 | 0.0270 | 1 | 1 |
| 5-hydroxytryptamine receptor 1A | Homo sapiens (human) | Kd | 0.4287 | 1 | 2 |
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | Kd | 0.2630 | 2 | 11 |
| 5-hydroxytryptamine receptor 1B | Homo sapiens (human) | EC50 | 5.0119 | 1 | 1 |
| 5-hydroxytryptamine receptor 2A | Homo sapiens (human) | EC50 | 2.5065 | 2 | 2 |
| 5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | Kd | 0.0015 | 2 | 2 |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | EC50 | 5.0119 | 1 | 1 |
| 5-hydroxytryptamine receptor 2B | Rattus norvegicus (Norway rat) | Kd | 0.0015 | 2 | 2 |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | EC50 | 5.0119 | 1 | 1 |
| 5-hydroxytryptamine receptor 2C | Rattus norvegicus (Norway rat) | Kd | 0.0015 | 2 | 2 |
| 5-hydroxytryptamine receptor 6 | Homo sapiens (human) | EC50 | 5.0119 | 1 | 1 |
| 5-hydroxytryptamine receptor 7 | Homo sapiens (human) | EC50 | 5.0119 | 1 | 1 |
| 5'-AMP-activated protein kinase catalytic subunit alpha-1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| 5'-AMP-activated protein kinase subunit gamma-1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| 5'-AMP-activated protein kinase subunit gamma-2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| AarF domain-containing protein kinase 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Actin-related protein 2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Actin-related protein 3 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Activated CDC42 kinase 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Activin receptor type-1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Activin receptor type-1B | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Activin receptor type-2B | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Acyl-CoA dehydrogenase family member 10 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Acyl-CoA dehydrogenase family member 11 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Adenine phosphoribosyltransferase | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Adenosine kinase | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Adenosine receptor A2a | Homo sapiens (human) | EC50 | 5.0119 | 1 | 1 |
| Adenosine receptor A3 | Homo sapiens (human) | EC50 | 5.0119 | 1 | 1 |
| Adenylate cyclase type 1 | Homo sapiens (human) | EC50 | 0.5000 | 1 | 1 |
| Adenylate cyclase type 2 | Rattus norvegicus (Norway rat) | EC50 | 2.0000 | 1 | 1 |
| Adenylate cyclase type 8 | Homo sapiens (human) | EC50 | 0.0937 | 1 | 1 |
| Adenylate kinase 2, mitochondrial | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| ADP/ATP translocase 2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| ADP/ATP translocase 3 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Albumin | Homo sapiens (human) | Kd | 520.3425 | 6 | 6 |
| Alpha-1A adrenergic receptor | Bos taurus (cattle) | EC50 | 1.1320 | 1 | 1 |
| Alpha-1A adrenergic receptor | Homo sapiens (human) | EC50 | 1.7049 | 3 | 3 |
| Alpha-1A adrenergic receptor | Homo sapiens (human) | Kd | 33.3424 | 2 | 3 |
| Alpha-1A adrenergic receptor | Oryctolagus cuniculus (rabbit) | Kd | 0.0125 | 1 | 2 |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | Kd | 0.1141 | 14 | 20 |
| Alpha-1B adrenergic receptor | Homo sapiens (human) | EC50 | 0.0011 | 2 | 2 |
| Alpha-1B adrenergic receptor | Homo sapiens (human) | Kd | 14.2967 | 3 | 7 |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | Kd | 0.1330 | 12 | 17 |
| Alpha-1B adrenergic receptor | Cricetulus griseus (Chinese hamster) | EC50 | 0.9430 | 1 | 1 |
| Alpha-1D adrenergic receptor | Homo sapiens (human) | Kd | 33.3424 | 2 | 3 |
| Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | Kd | 0.1256 | 13 | 18 |
| Alpha-2A adrenergic receptor | Homo sapiens (human) | EC50 | 4.6372 | 6 | 6 |
| Alpha-2A adrenergic receptor | Rattus norvegicus (Norway rat) | EC50 | 0.0270 | 1 | 2 |
| Alpha-2A adrenergic receptor | Homo sapiens (human) | Kd | 100.0000 | 1 | 1 |
| Alpha-2A adrenergic receptor | Rattus norvegicus (Norway rat) | Kd | 1.1594 | 8 | 11 |
| Alpha-2B adrenergic receptor | Homo sapiens (human) | EC50 | 7.6420 | 3 | 3 |
| Alpha-2B adrenergic receptor | Rattus norvegicus (Norway rat) | EC50 | 0.0363 | 2 | 3 |
| Alpha-2B adrenergic receptor | Homo sapiens (human) | Kd | 100.0000 | 1 | 1 |
| Alpha-2B adrenergic receptor | Rattus norvegicus (Norway rat) | Kd | 1.1594 | 8 | 11 |
| Alpha-2C adrenergic receptor | Homo sapiens (human) | EC50 | 4.6374 | 6 | 6 |
| Alpha-2C adrenergic receptor | Rattus norvegicus (Norway rat) | EC50 | 0.0270 | 1 | 2 |
| Alpha-2C adrenergic receptor | Homo sapiens (human) | Kd | 100.0000 | 1 | 1 |
| Alpha-2C adrenergic receptor | Rattus norvegicus (Norway rat) | Kd | 1.1594 | 8 | 11 |
| Alpha-mannosidase 2C1 | Rattus norvegicus (Norway rat) | Kd | 3.7154 | 1 | 1 |
| Amine oxidase [flavin-containing] A | Rattus norvegicus (Norway rat) | EC50 | 10.0000 | 1 | 1 |
| Androgen receptor | Homo sapiens (human) | EC50 | 20.0000 | 1 | 2 |
| Angiotensin-converting enzyme | Homo sapiens (human) | EC50 | 487.4692 | 3 | 3 |
| Angiotensin-converting enzyme 2 | Homo sapiens (human) | EC50 | 10.0000 | 1 | 2 |
| AP2-associated protein kinase 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Apelin receptor | Homo sapiens (human) | EC50 | 0.0170 | 5 | 5 |
| Aspartate aminotransferase, cytoplasmic | Homo sapiens (human) | Kd | 16.5400 | 1 | 1 |
| ATP-binding cassette sub-family C member 8 | Homo sapiens (human) | EC50 | 23.0167 | 6 | 6 |
| ATP-dependent 6-phosphofructokinase, platelet type | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| ATP-dependent RNA helicase DDX1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| ATP-dependent RNA helicase DDX3X | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| ATP-dependent RNA helicase DDX42 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| ATP-dependent RNA helicase DHX30 | Homo sapiens (human) | Kd | 30.0000 | 1 | 2 |
| ATP-dependent translocase ABCB1 | Homo sapiens (human) | Kd | 4.4668 | 1 | 1 |
| ATP-dependent translocase ABCB1 | Mus musculus (house mouse) | Kd | 4.7500 | 2 | 2 |
| ATP-sensitive inward rectifier potassium channel 11 | Homo sapiens (human) | EC50 | 23.0167 | 6 | 6 |
| Atypical kinase COQ8A, mitochondrial | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Aurora kinase A | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Aurora kinase B | Homo sapiens (human) | Kd | 15.5700 | 2 | 2 |
| Beta-1 adrenergic receptor | Homo sapiens (human) | Kd | 3.7596 | 8 | 37 |
| Beta-1 adrenergic receptor | Rattus norvegicus (Norway rat) | Kd | 0.0236 | 3 | 9 |
| Beta-1 adrenergic receptor | Cavia porcellus (domestic guinea pig) | Kd | 0.2434 | 15 | 22 |
| Beta-2 adrenergic receptor | Cavia porcellus (domestic guinea pig) | Kd | 0.2260 | 6 | 20 |
| Beta-2 adrenergic receptor | Homo sapiens (human) | Kd | 3.9796 | 11 | 45 |
| Beta-2 adrenergic receptor | Bos taurus (cattle) | Kd | 186.2100 | 1 | 1 |
| Beta-3 adrenergic receptor | Homo sapiens (human) | Kd | 4.0762 | 6 | 32 |
| Beta-adrenergic receptor kinase 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Beta-lactamase class B VIM-2 | Pseudomonas aeruginosa | Kd | 0.6000 | 1 | 1 |
| BMP-2-inducible protein kinase | Homo sapiens (human) | Kd | 33.7880 | 1 | 1 |
| Bone morphogenetic protein receptor type-1A | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Bone morphogenetic protein receptor type-1B | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Bone morphogenetic protein receptor type-2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Breakpoint cluster region protein | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Calcium/calmodulin-dependent protein kinase kinase 2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Calcium/calmodulin-dependent protein kinase type II subunit delta | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Calcium/calmodulin-dependent protein kinase type II subunit gamma | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Calcium/calmodulin-dependent protein kinase type IV | Homo sapiens (human) | Kd | 30.0000 | 1 | 2 |
| cAMP-dependent protein kinase catalytic subunit alpha | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| cAMP-dependent protein kinase catalytic subunit beta | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| cAMP-dependent protein kinase catalytic subunit gamma | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| cAMP-dependent protein kinase type II-alpha regulatory subunit | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Cannabinoid receptor 2 | Homo sapiens (human) | EC50 | 0.0983 | 4 | 4 |
| Carbonic anhydrase 1 | Homo sapiens (human) | Kd | 5.5957 | 5 | 9 |
| Carbonic anhydrase 12 | Homo sapiens (human) | Kd | 1.9390 | 4 | 8 |
| Carbonic anhydrase 13 | Homo sapiens (human) | Kd | 1.2794 | 6 | 10 |
| Carbonic anhydrase 14 | Homo sapiens (human) | Kd | 0.0317 | 2 | 2 |
| Carbonic anhydrase 2 | Homo sapiens (human) | Kd | 1.2213 | 7 | 11 |
| Carbonic anhydrase 3 | Homo sapiens (human) | Kd | 14.0525 | 2 | 2 |
| Carbonic anhydrase 4 | Homo sapiens (human) | Kd | 0.0387 | 2 | 2 |
| Carbonic anhydrase 5A, mitochondrial | Homo sapiens (human) | Kd | 0.3385 | 2 | 2 |
| Carbonic anhydrase 5B, mitochondrial | Homo sapiens (human) | Kd | 0.0297 | 2 | 2 |
| Carbonic anhydrase 6 | Homo sapiens (human) | Kd | 0.3203 | 3 | 3 |
| Carbonic anhydrase 7 | Homo sapiens (human) | Kd | 1.4751 | 6 | 10 |
| Carbonic anhydrase 9 | Homo sapiens (human) | Kd | 0.2160 | 2 | 2 |
| Casein kinase I isoform alpha | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Casein kinase I isoform delta | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Casein kinase I isoform epsilon | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Casein kinase I isoform gamma-1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Casein kinase I isoform gamma-2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Casein kinase I isoform gamma-3 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Casein kinase II subunit alpha' | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Cell division cycle 7-related protein kinase | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| cGMP-dependent protein kinase 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Cholecystokinin receptor type A | Homo sapiens (human) | EC50 | 5.0119 | 1 | 1 |
| Choline-phosphate cytidylyltransferase A | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Chromodomain-helicase-DNA-binding protein 4 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Citron Rho-interacting kinase | Homo sapiens (human) | Kd | 48.8760 | 1 | 1 |
| Cyclin-dependent kinase 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Cyclin-dependent kinase 12 | Homo sapiens (human) | Kd | 3.4800 | 1 | 1 |
| Cyclin-dependent kinase 13 | Homo sapiens (human) | Kd | 4.5180 | 1 | 1 |
| Cyclin-dependent kinase 16 | Homo sapiens (human) | Kd | 30.0000 | 1 | 2 |
| Cyclin-dependent kinase 17 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Cyclin-dependent kinase 2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Cyclin-dependent kinase 3 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Cyclin-dependent kinase 4 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Cyclin-dependent kinase 6 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Cyclin-dependent kinase 7 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Cyclin-dependent kinase 9 | Homo sapiens (human) | Kd | 4.2510 | 1 | 1 |
| Cyclin-dependent-like kinase 5 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Cyclin-G-associated kinase | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Cysteine--tRNA ligase, cytoplasmic | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Cystic fibrosis transmembrane conductance regulator | Homo sapiens (human) | Kd | 189.3000 | 1 | 1 |
| Cytochrome c1, heme protein, mitochondrial | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| D | Rattus norvegicus (Norway rat) | EC50 | 0.0570 | 1 | 1 |
| D(1A) dopamine receptor | Homo sapiens (human) | EC50 | 1.6821 | 3 | 3 |
| D(1A) dopamine receptor | Homo sapiens (human) | Kd | 0.0280 | 1 | 1 |
| D(2) dopamine receptor | Homo sapiens (human) | EC50 | 5.0119 | 1 | 1 |
| D(2) dopamine receptor | Rattus norvegicus (Norway rat) | Kd | 4.0400 | 4 | 5 |
| dCTP pyrophosphatase 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 2 |
| Delta-type opioid receptor | Homo sapiens (human) | EC50 | 5.0119 | 1 | 1 |
| Delta(24)-sterol reductase | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Deoxycytidine kinase | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Discoidin domain-containing receptor 2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| DNA replication licensing factor MCM4 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| DNA topoisomerase 2-alpha | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| DNA topoisomerase 2-beta | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| DnaJ homolog subfamily A member 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Dual specificity mitogen-activated protein kinase kinase 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Dual specificity mitogen-activated protein kinase kinase 2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Dual specificity mitogen-activated protein kinase kinase 3 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Dual specificity mitogen-activated protein kinase kinase 5 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Dual specificity mitogen-activated protein kinase kinase 6 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Dual specificity protein kinase CLK1 | Homo sapiens (human) | Kd | 0.1520 | 1 | 1 |
| Dual specificity protein kinase CLK2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Dual specificity protein kinase CLK3 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Dual specificity protein kinase CLK4 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Dual specificity protein kinase TTK | Homo sapiens (human) | Kd | 30.0000 | 1 | 2 |
| Dual specificity testis-specific protein kinase 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Dual specificity testis-specific protein kinase 2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Dual specificity tyrosine-phosphorylation-regulated kinase 1A | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Dynamin-like 120 kDa protein, mitochondrial | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| EKC/KEOPS complex subunit TP53RK | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Electron transfer flavoprotein subunit beta | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Elongation factor Tu, mitochondrial | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Endothelin receptor type B | Bos taurus (cattle) | Kd | 0.0724 | 1 | 1 |
| Endothelin receptor type B | Homo sapiens (human) | Kd | 0.0724 | 1 | 1 |
| Endothelin-1 receptor | Homo sapiens (human) | EC50 | 5.0119 | 1 | 1 |
| Endothelin-1 receptor | Rattus norvegicus (Norway rat) | Kd | 0.0561 | 2 | 2 |
| Envelope glycoprotein | Ebola virus - Mayinga, Zaire, 1976 | Kd | 290.0000 | 1 | 1 |
| Ephrin type-A receptor 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Ephrin type-A receptor 2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Ephrin type-A receptor 4 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Ephrin type-A receptor 5 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Ephrin type-A receptor 7 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Ephrin type-B receptor 2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Ephrin type-B receptor 3 | Homo sapiens (human) | Kd | 30.0000 | 1 | 2 |
| Ephrin type-B receptor 4 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Ephrin type-B receptor 6 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Epidermal growth factor receptor | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Epithelial discoidin domain-containing receptor 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Estrogen receptor | Homo sapiens (human) | EC50 | 20.0000 | 1 | 2 |
| Estrogen receptor beta | Homo sapiens (human) | EC50 | 11.6500 | 1 | 2 |
| Eukaryotic peptide chain release factor GTP-binding subunit ERF3B | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Eukaryotic translation initiation factor 2-alpha kinase 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Eukaryotic translation initiation factor 5B | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Exosome RNA helicase MTR4 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Ferrochelatase, mitochondrial | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Fibroblast growth factor receptor 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Focal adhesion kinase 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| G protein-activated inward rectifier potassium channel 1 | Rattus norvegicus (Norway rat) | EC50 | 0.0820 | 1 | 1 |
| G protein-coupled receptor kinase 6 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| G-protein coupled receptor 35 | Homo sapiens (human) | EC50 | 6.2650 | 2 | 2 |
| GABA theta subunit | Rattus norvegicus (Norway rat) | Kd | 0.2890 | 1 | 5 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | Kd | 0.2890 | 1 | 5 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | Kd | 0.2890 | 1 | 5 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | Kd | 0.2890 | 1 | 5 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | Rattus norvegicus (Norway rat) | Kd | 0.2890 | 1 | 5 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | Rattus norvegicus (Norway rat) | Kd | 0.2890 | 1 | 5 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | Rattus norvegicus (Norway rat) | Kd | 0.2890 | 1 | 5 |
| Gamma-aminobutyric acid receptor subunit beta-1 | Rattus norvegicus (Norway rat) | Kd | 0.2890 | 1 | 5 |
| Gamma-aminobutyric acid receptor subunit beta-2 | Rattus norvegicus (Norway rat) | Kd | 0.2890 | 1 | 5 |
| Gamma-aminobutyric acid receptor subunit beta-3 | Rattus norvegicus (Norway rat) | Kd | 0.2890 | 1 | 5 |
| Gamma-aminobutyric acid receptor subunit delta | Rattus norvegicus (Norway rat) | Kd | 0.2890 | 1 | 5 |
| Gamma-aminobutyric acid receptor subunit epsilon | Rattus norvegicus (Norway rat) | Kd | 0.2890 | 1 | 5 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | Rattus norvegicus (Norway rat) | Kd | 0.2890 | 1 | 5 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | Rattus norvegicus (Norway rat) | Kd | 0.2890 | 1 | 5 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | Rattus norvegicus (Norway rat) | Kd | 0.2890 | 1 | 5 |
| Gamma-aminobutyric acid receptor subunit pi | Rattus norvegicus (Norway rat) | Kd | 0.2890 | 1 | 5 |
| General transcription and DNA repair factor IIH helicase subunit XPD | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Glucocorticoid receptor | Homo sapiens (human) | EC50 | 20.0000 | 1 | 2 |
| Glutamate receptor 1 | Homo sapiens (human) | EC50 | 19.2333 | 6 | 6 |
| Glutamate receptor 2 | Homo sapiens (human) | EC50 | 38.4880 | 5 | 5 |
| Glutamate receptor 2 | Rattus norvegicus (Norway rat) | EC50 | 7.6000 | 1 | 1 |
| Glutamate receptor 3 | Homo sapiens (human) | EC50 | 13.7000 | 1 | 1 |
| Glutamate receptor 4 | Homo sapiens (human) | EC50 | 3.8000 | 2 | 2 |
| Glycine receptor subunit alpha-1 | Homo sapiens (human) | EC50 | 3.2000 | 1 | 1 |
| Glycine--tRNA ligase | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Glycogen phosphorylase, brain form | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Glycogen phosphorylase, liver form | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Glycogen synthase kinase-3 alpha | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Glycogen synthase kinase-3 beta | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| GTP-binding nuclear protein Ran | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Guanine nucleotide-binding protein G(i) subunit alpha-2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Heme oxygenase 2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Hepatocyte growth factor receptor | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| High affinity nerve growth factor receptor | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Hsf1 protein | Mus musculus (house mouse) | EC50 | 195.0000 | 1 | 2 |
| Inhibitor of nuclear factor kappa-B kinase subunit epsilon | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Inosine-5'-monophosphate dehydrogenase 2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Insulin receptor | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Insulin-like growth factor 1 receptor | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Integrin-linked protein kinase | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Interleukin-1 receptor-associated kinase 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Interleukin-1 receptor-associated kinase 3 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Interleukin-1 receptor-associated kinase 4 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Kappa-type opioid receptor | Homo sapiens (human) | EC50 | 5.0119 | 1 | 1 |
| Leukotriene A-4 hydrolase | Homo sapiens (human) | Kd | 7.0300 | 3 | 3 |
| Leukotriene B4 receptor 2 | Homo sapiens (human) | EC50 | 10.4700 | 1 | 3 |
| LIM domain kinase 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| LIM domain kinase 2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 2 |
| Long-chain-fatty-acid--CoA ligase 5 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Macrophage-stimulating protein receptor | Homo sapiens (human) | Kd | 30.0000 | 1 | 2 |
| MAP kinase-activated protein kinase 2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| MAP kinase-activated protein kinase 5 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| MAP/microtubule affinity-regulating kinase 3 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| MAP/microtubule affinity-regulating kinase 4 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Maternal embryonic leucine zipper kinase | Homo sapiens (human) | Kd | 1.9220 | 1 | 1 |
| Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Metallo-beta-lactamase type 2 | Klebsiella pneumoniae | Kd | 14.0627 | 1 | 2 |
| Midasin | Homo sapiens (human) | Kd | 30.0000 | 1 | 2 |
| Mineralocorticoid receptor | Homo sapiens (human) | EC50 | 0.1000 | 1 | 1 |
| Mitogen-activated protein kinase 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 2 |
| Mitogen-activated protein kinase 10 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Mitogen-activated protein kinase 11 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Mitogen-activated protein kinase 14 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Mitogen-activated protein kinase 15 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Mitogen-activated protein kinase 3 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Mitogen-activated protein kinase 7 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Mitogen-activated protein kinase 8 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Mitogen-activated protein kinase 9 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Mitogen-activated protein kinase kinase kinase 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Mitogen-activated protein kinase kinase kinase 11 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Mitogen-activated protein kinase kinase kinase 2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Mitogen-activated protein kinase kinase kinase 20 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Mitogen-activated protein kinase kinase kinase 3 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Mitogen-activated protein kinase kinase kinase 4 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Mitogen-activated protein kinase kinase kinase 5 | Homo sapiens (human) | Kd | 30.0000 | 1 | 2 |
| Mitogen-activated protein kinase kinase kinase 6 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Mitogen-activated protein kinase kinase kinase kinase 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Mitogen-activated protein kinase kinase kinase kinase 2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Mitogen-activated protein kinase kinase kinase kinase 3 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Mitogen-activated protein kinase kinase kinase kinase 4 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Mitogen-activated protein kinase kinase kinase kinase 5 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Mitotic checkpoint serine/threonine-protein kinase BUB1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Mu-type opioid receptor | Cavia porcellus (domestic guinea pig) | EC50 | 1,422.6600 | 1 | 1 |
| Mu-type opioid receptor | Homo sapiens (human) | EC50 | 5.0119 | 1 | 1 |
| Multifunctional protein ADE2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | EC50 | 5.0119 | 1 | 1 |
| Muscarinic acetylcholine receptor M2 | Homo sapiens (human) | EC50 | 5.0119 | 1 | 1 |
| Muscarinic acetylcholine receptor M3 | Homo sapiens (human) | EC50 | 5.0119 | 1 | 1 |
| Myosin light chain kinase 3 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Myosin light chain kinase, smooth muscle | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Myosin-10 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Myosin-14 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Neuromedin-K receptor | Cavia porcellus (domestic guinea pig) | Kd | 0.0024 | 1 | 1 |
| Nicotinamide phosphoribosyltransferase | Homo sapiens (human) | Kd | 230.0000 | 1 | 1 |
| Non-receptor tyrosine-protein kinase TNK1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Non-receptor tyrosine-protein kinase TYK2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| NUAK family SNF1-like kinase 2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Nuclear receptor subfamily 1 group I member 2 | Homo sapiens (human) | EC50 | 10.5559 | 5 | 16 |
| Nuclear receptor subfamily 1 group I member 2 | Rattus norvegicus (Norway rat) | EC50 | 23.5125 | 1 | 4 |
| Nuclear receptor subfamily 2 group E member 1 | Homo sapiens (human) | EC50 | 33.6667 | 3 | 3 |
| Nuclear receptor subfamily 2 group E member 1 | Homo sapiens (human) | Kd | 0.5000 | 1 | 1 |
| Nucleolar GTP-binding protein 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 2 |
| Obg-like ATPase 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| ORF73 | Human gammaherpesvirus 8 | EC50 | 75.0000 | 1 | 1 |
| PAS domain-containing serine/threonine-protein kinase | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Peroxisomal acyl-coenzyme A oxidase 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Peroxisomal acyl-coenzyme A oxidase 3 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Peroxisome proliferator-activated receptor alpha | Homo sapiens (human) | EC50 | 10.0000 | 1 | 1 |
| Peroxisome proliferator-activated receptor alpha | Mus musculus (house mouse) | EC50 | 10.0000 | 1 | 1 |
| Peroxisome proliferator-activated receptor delta | Homo sapiens (human) | EC50 | 10.0000 | 1 | 1 |
| Peroxisome proliferator-activated receptor delta | Mus musculus (house mouse) | EC50 | 10.0000 | 1 | 1 |
| Peroxisome proliferator-activated receptor gamma | Homo sapiens (human) | EC50 | 3.1277 | 13 | 13 |
| Peroxisome proliferator-activated receptor gamma | Mus musculus (house mouse) | EC50 | 4.0600 | 1 | 1 |
| Phenylalanine--tRNA ligase beta subunit | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Phosphatidylethanolamine-binding protein 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Phosphorylase b kinase gamma catalytic chain, liver/testis isoform | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Platelet glycoprotein VI | Homo sapiens (human) | Kd | 185.0000 | 2 | 4 |
| Platelet-derived growth factor receptor beta | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Potassium channel subfamily K member 2 | Homo sapiens (human) | EC50 | 0.4300 | 1 | 1 |
| Probable ATP-dependent RNA helicase DDX6 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Procathepsin L | Homo sapiens (human) | EC50 | 10.0000 | 1 | 2 |
| Progesterone receptor | Homo sapiens (human) | EC50 | 20.0000 | 1 | 2 |
| Prostacyclin receptor | Homo sapiens (human) | EC50 | 5.0009 | 2 | 2 |
| Prostaglandin D2 receptor | Homo sapiens (human) | EC50 | 0.0006 | 1 | 1 |
| Prostaglandin E2 receptor EP1 subtype | Homo sapiens (human) | EC50 | 0.2850 | 1 | 1 |
| Prostaglandin E2 receptor EP2 subtype | Homo sapiens (human) | EC50 | 0.0062 | 1 | 1 |
| Prostaglandin E2 receptor EP3 subtype | Homo sapiens (human) | EC50 | 3.4000 | 1 | 1 |
| Prostaglandin F2-alpha receptor | Homo sapiens (human) | EC50 | 0.0036 | 1 | 1 |
| Prostaglandin F2-alpha receptor | Mus musculus (house mouse) | EC50 | 0.0190 | 2 | 2 |
| Protein kinase C alpha type | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Protein kinase C beta type | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Protein kinase C delta type | Homo sapiens (human) | Kd | 4.7890 | 1 | 1 |
| Protein kinase C iota type | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Protein kinase C theta type | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Protein kinase C zeta type | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Protein-tyrosine kinase 2-beta | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Protein-tyrosine kinase 6 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Proto-oncogene tyrosine-protein kinase receptor Ret | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Proto-oncogene tyrosine-protein kinase Src | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Putative heat shock protein HSP 90-beta 2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Pyridoxal kinase | Homo sapiens (human) | Kd | 30.0000 | 1 | 2 |
| RAC-alpha serine/threonine-protein kinase | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| RAC-beta serine/threonine-protein kinase | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| RAC-gamma serine/threonine-protein kinase | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Ras-related C3 botulinum toxin substrate 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Ras-related protein Rab-10 | Homo sapiens (human) | Kd | 30.0000 | 1 | 2 |
| Ras-related protein Rab-27A | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Ras-related protein Rab-6A | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Receptor-interacting serine/threonine-protein kinase 2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Receptor-interacting serine/threonine-protein kinase 3 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Receptor-type tyrosine-protein kinase FLT3 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Relaxin receptor 1 | Homo sapiens (human) | EC50 | 0.0470 | 1 | 1 |
| Renin | Homo sapiens (human) | Kd | 0.0001 | 1 | 1 |
| Replicase polyprotein 1a | Severe acute respiratory syndrome-related coronavirus | EC50 | 10.0000 | 1 | 2 |
| Replicase polyprotein 1ab | Betacoronavirus England 1 | EC50 | 10.0000 | 1 | 2 |
| Replicase polyprotein 1ab | Human coronavirus 229E | EC50 | 10.0000 | 1 | 2 |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | EC50 | 6.6703 | 2 | 3 |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome-related coronavirus | EC50 | 10.0000 | 1 | 2 |
| Rho-associated protein kinase 1 | Homo sapiens (human) | Kd | 0.9060 | 1 | 1 |
| Rho-associated protein kinase 2 | Homo sapiens (human) | Kd | 0.5105 | 2 | 2 |
| Ribosomal protein S6 kinase alpha-1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Ribosomal protein S6 kinase alpha-3 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Ribosomal protein S6 kinase alpha-4 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Ribosomal protein S6 kinase alpha-5 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Ribosomal protein S6 kinase alpha-6 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Ribosomal protein S6 kinase beta-1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Ribosyldihydronicotinamide dehydrogenase [quinone] | Homo sapiens (human) | Kd | 2.4510 | 1 | 1 |
| RNA cytidine acetyltransferase | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| S-adenosylmethionine synthase isoform type-2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Septin-9 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase 10 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase 16 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase 26 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase 3 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| serine/threonine-protein kinase 33 isoform a | Homo sapiens (human) | EC50 | 9.5830 | 1 | 1 |
| Serine/threonine-protein kinase 4 | Homo sapiens (human) | Kd | 30.0000 | 1 | 2 |
| Serine/threonine-protein kinase A-Raf | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase B-raf | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase Chk1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase D2 | Homo sapiens (human) | Kd | 6.4160 | 1 | 1 |
| Serine/threonine-protein kinase D3 | Homo sapiens (human) | Kd | 23.3410 | 1 | 1 |
| Serine/threonine-protein kinase LATS1 | Homo sapiens (human) | Kd | 4.1700 | 1 | 1 |
| Serine/threonine-protein kinase MARK2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase MRCK alpha | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase MRCK beta | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase MRCK gamma | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase N1 | Homo sapiens (human) | Kd | 0.8410 | 1 | 1 |
| Serine/threonine-protein kinase N2 | Homo sapiens (human) | Kd | 2.5990 | 1 | 1 |
| Serine/threonine-protein kinase N3 | Homo sapiens (human) | Kd | 0.0990 | 1 | 1 |
| Serine/threonine-protein kinase Nek1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase Nek2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase Nek3 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase Nek7 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase Nek9 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase NLK | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase PAK 2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase PAK 4 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase pim-1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase PLK1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 2 |
| Serine/threonine-protein kinase PLK4 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase SIK2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase SIK3 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase STK11 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase TAO1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase TAO2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase TAO3 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase TBK1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase ULK1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase ULK3 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase/endoribonuclease IRE1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase/endoribonuclease IRE2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| short transient receptor potential channel 6 isoform 1 | Mus musculus (house mouse) | EC50 | 44.6700 | 1 | 1 |
| Signal recognition particle receptor subunit alpha | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Solute carrier family 2, facilitated glucose transporter member 1 | Homo sapiens (human) | Kd | 5.0000 | 1 | 1 |
| Spike glycoprotein | Betacoronavirus England 1 | EC50 | 10.0000 | 1 | 2 |
| Spike glycoprotein | Severe acute respiratory syndrome-related coronavirus | EC50 | 10.0000 | 1 | 2 |
| STE20-like serine/threonine-protein kinase | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| STE20-related kinase adapter protein alpha | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Structural maintenance of chromosomes protein 1A | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Structural maintenance of chromosomes protein 2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Succinate--CoA ligase [ADP-forming] subunit beta, mitochondrial | Homo sapiens (human) | Kd | 30.0000 | 1 | 2 |
| Synaptic vesicular amine transporter | Homo sapiens (human) | Kd | 0.0080 | 1 | 1 |
| TGF-beta receptor type-1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| TGF-beta receptor type-2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Thymidine phosphorylase | Homo sapiens (human) | EC50 | 1,422.6600 | 1 | 1 |
| Thyroid hormone receptor-associated protein 3 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| TRAF2 and NCK-interacting protein kinase | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Transient receptor potential cation channel subfamily A member 1 | Mus musculus (house mouse) | EC50 | 2.3000 | 1 | 2 |
| Transient receptor potential cation channel subfamily V member 1 | Homo sapiens (human) | EC50 | 10.0000 | 2 | 2 |
| Transmembrane protease serine 2 | Homo sapiens (human) | EC50 | 7.0000 | 2 | 3 |
| Tubulin alpha-1A chain | Homo sapiens (human) | Kd | 149.7630 | 1 | 2 |
| Tubulin alpha-1B chain | Homo sapiens (human) | Kd | 149.7630 | 1 | 2 |
| Tubulin alpha-1C chain | Homo sapiens (human) | Kd | 149.7630 | 1 | 2 |
| Tubulin alpha-3C chain | Homo sapiens (human) | Kd | 149.7630 | 1 | 2 |
| Tubulin alpha-3E chain | Homo sapiens (human) | Kd | 149.7630 | 1 | 2 |
| Tubulin alpha-4A chain | Homo sapiens (human) | Kd | 149.7630 | 1 | 2 |
| Tubulin beta chain | Homo sapiens (human) | Kd | 149.7630 | 1 | 2 |
| Tubulin beta-1 chain | Homo sapiens (human) | Kd | 149.7630 | 1 | 2 |
| Tubulin beta-2A chain | Homo sapiens (human) | Kd | 149.7630 | 1 | 2 |
| Tubulin beta-2B chain | Homo sapiens (human) | Kd | 149.7630 | 1 | 2 |
| Tubulin beta-3 chain | Homo sapiens (human) | Kd | 149.7630 | 1 | 2 |
| Tubulin beta-4A chain | Homo sapiens (human) | Kd | 149.7630 | 1 | 2 |
| Tubulin beta-4B chain | Homo sapiens (human) | Kd | 149.7630 | 1 | 2 |
| Tubulin beta-6 chain | Homo sapiens (human) | Kd | 149.7630 | 1 | 2 |
| Tubulin beta-8 chain | Homo sapiens (human) | Kd | 149.7630 | 1 | 2 |
| Type-1 angiotensin II receptor | Homo sapiens (human) | EC50 | 8.3373 | 3 | 3 |
| Type-1 angiotensin II receptor | Cavia porcellus (domestic guinea pig) | Kd | 0.0126 | 1 | 1 |
| Type-1 angiotensin II receptor | Homo sapiens (human) | Kd | 0.0048 | 1 | 2 |
| Type-1 angiotensin II receptor | Oryctolagus cuniculus (rabbit) | Kd | 0.0426 | 5 | 6 |
| Type-1A angiotensin II receptor | Rattus norvegicus (Norway rat) | EC50 | 10.0000 | 1 | 1 |
| Type-1A angiotensin II receptor | Rattus norvegicus (Norway rat) | Kd | 0.0066 | 1 | 2 |
| Tyrosine--tRNA ligase, cytoplasmic | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Tyrosine-protein kinase ABL1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Tyrosine-protein kinase ABL2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 2 |
| Tyrosine-protein kinase BTK | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Tyrosine-protein kinase CSK | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Tyrosine-protein kinase Fer | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Tyrosine-protein kinase Fes/Fps | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Tyrosine-protein kinase Fgr | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Tyrosine-protein kinase FRK | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Tyrosine-protein kinase Fyn | Homo sapiens (human) | Kd | 30.0000 | 1 | 2 |
| Tyrosine-protein kinase HCK | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Tyrosine-protein kinase JAK1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Tyrosine-protein kinase Lck | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Tyrosine-protein kinase Lyn | Homo sapiens (human) | Kd | 30.0000 | 1 | 2 |
| Tyrosine-protein kinase SYK | Homo sapiens (human) | EC50 | 300.0000 | 1 | 1 |
| Tyrosine-protein kinase SYK | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Tyrosine-protein kinase Tec | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Tyrosine-protein kinase Yes | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| U5 small nuclear ribonucleoprotein 200 kDa helicase | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| UMP-CMP kinase | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Uncharacterized aarF domain-containing protein kinase 5 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Uncharacterized protein FLJ45252 | Homo sapiens (human) | Kd | 30.0000 | 1 | 2 |
| Vasopressin V1a receptor | Homo sapiens (human) | EC50 | 5.0119 | 1 | 1 |
| Very long-chain specific acyl-CoA dehydrogenase, mitochondrial | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Wee1-like protein kinase | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |